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ABSTRACT 
 Resistant starch (RS) is not digested in the small intestine and is available for 
fermentation by the colonic microbiota, producing metabolites including short chain fatty acids 
(SCFAs). We hypothesized that diets containing resistant starch, serving as a prebiotic, will have 
inhibitory effects, mediated through the products of microbial fermentation, on the canonical Wnt 
signaling pathway.   To test this hypothesis, we examined the molecular and morphologic effects 
of diets containing resistant starches on the early stage of colorectal carcinogenesis in 
azoxymethane-induced rat and mouse models. The first study examined the effects of diets 
containing naturally occurring resistant starch from Latin American corn strains, GUAT (18.6%) 
and AR (5.4%), and their hybrid, ARxGUAT (8.6%), for effects on the pre-neoplastic stages of 
azoxymethane-induced colonic epithelial damage in Fisher 344 rats.  Genes of the Wnt signaling 
pathway were selected and analyzed for expression levels by semi-quantitative, real-time 
polymerase chain reaction analysis (semi-qRT-PCR).  In the second study, the effects of diets 
including a stearic-acid complexed high-amylose cornstarch (SA-HA7) (31.1%), a high amylose 
starch (HA7) (19.0%), a chemically modified starch (OS-HA7) (4.7%), were compared with 
normal corn starch (CS) (3.7%), for the effects on azoxymethane-induced colonic epithelial 
damage in A/J mice, as tested by mRNA levels of the same genes as the first study.  Being able 
to demonstrate inhibitory effects of resistant starch, on the Wnt pathway will provide a potential 
means to prevent the initiation and proliferation of colorectal carcinogenesis.  In the first study, 
the GUAT diet did not inhibit development of the putative preneoplastic lesion, aberrant crypt 
focus (ACF).  However, mRNA encoding β-catenin was significantly decreased in AOM-
injected rats fed the GUAT diet compared with the saline-injected rats fed the GUAT diet, while 
no similar decrease was seen in diets low in resistant starch.  In the second study, mice fed a diet 
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containing a high level of resistant starch, SA-HA7, had lower mRNA expression of several 
targets, with the exception of β-catenin mRNA, relative to the mice fed the control diet.  Overall, 
this suggests a potential ability of resistant starch to regulate β-catenin expression, and thus the 
Wnt signaling pathway.  
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CHAPTER 1: GENERAL INTRODUCTION 
Introduction 
 Resistant starch is a starch that escapes digestion in the small intestine and is available for 
fermentation in the colon (Englyst, 1986).  The products of this fermentation by colonic bacteria 
include short chain fatty acids (SCFAs), molecules that have been shown to have a protective 
effect on the epithelial cells of the colon  (Cummings, et al., 1996).  Butyrate, acetate, and 
propionate are the three primary SCFAs, with butyrate believed to have the greatest effects on 
the colon, and have been shown to play an important role in inhibiting proliferation and inducing 
apoptosis in colonic epithelial cells (O'Keefe, et al., 2009). 
 Resistant starches have been shown, through both human and animal studies, to have 
many health benefits as a prebiotic, including protection against colonic DNA damage, obesity, 
diabetes, and chronic inflammatory bowel disease (Jacobasch, et al., 1999; Hasjim, et al., 2010; 
Lattimer and Haub, 2010).  Such benefits in animal studies suggest that there is strong potential 
for wide-spread health benefits for humans. 
 Naturally occurring resistant starch has been found in many plants.  Carbohydrates are 
stored in plants in the form of starch, with high concentrations in grains and seeds to provide a 
source of stored nutritional energy.  Chemically, starch molecules are polysaccharides composed 
of linear or helical amylose molecules or branched amylopectin which are stored in varying 
concentrations, depending on the relative activities of starch synthase and branching enzymes in 
each strain of plant. High concentrations of amylose correspond to increased digestion resistance 
because enzymatic action on a linear molecule occurs more slowly overall than on a branched 
molecule (Tharanathan, 2002). Five types of RS have currently been categorized, including 
physically inaccessible starch (RS1), naturally highly resistant starch to α-amylase digestion 
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(RS2), retrograded resistant starch (RS3), chemically modified starch (RS4), and amylose-lipid 
complexed starch (RS5).  Physicochemical modification and conjugation of various molecules 
are effective ways to increase the resistance of starch granules against enzymatic hydrolysis.  A 
novel starch (SA-HA7) was created by complexing a high-amylose starch with steric acid 
(Hasjim, et al., 2010).   
 The two studies in this thesis examined the inhibitory effect of cooked diets containing 
the resistant starches, GUAT, SA-HA7, and OS-HA7, on the azoxymethane-damaged colonic 
epithelium in rodent models.  The resistant starches are not always chemically modified;   
naturally occurring resistant starches are sometimes present in high concentrations in maize, such 
as the Guatemalan line, GUAT.  The starch in kernels of other lines, such as an Argentinean line, 
AR, has a low level of resistance to digestion and is high-yielding.  The variation in resistant 
starch content comes, in part, from the genetic make-up of the plant and the amylose to 
amylopectin ratio. For example, corn starch with the sbe1a mutation was reported to alter 
molecular structures resulting in a better resistance to pancreatic α-amylase, β-amylase, and 
isoamylase than wild type starch (Xia, et al., 2011). Parental lines, GUAT and AR, were crossed 
by members of the Resistant Starch PSI group, Dr. Susan Duvick and Dr. Linda Pollak, working 
in the Department of Agriculture at Iowa State University, in hopes that the best qualities of each 
parent, high resistance and high yielding, respectively, would be passed down to hybrid, 
ARxGUAT.   
 Effects of dietary resistant starch were determined by examining the mRNA expression 
levels of key genes of the Wnt signaling pathway, as it is an important regulator of proliferation 
and differentiation in the colonic epithelium.  The Wnt pathway regulates proliferation through 
the influence of Wnt family growth factors and controls migration of epithelial cells up the 
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colonic crypt.  Proliferation ceases after the cells have reached approximately two-thirds of the 
way up the crypt walls as the cells migrate away from the Wnt signal.  This epithelial 
proliferation and migration controlled by Wnt factors is called the non-canonical Wnt signaling 
pathway (Schneikert and Behrens, 2007).  When this system becomes deregulated (typically 
through up-regulation), a state designated the canonical Wnt pathway; control of epithelial cell 
growth is lost, with possible development of colorectal cancer.  Resistant starch, and thus the 
microbial metabolic product of resistant starch fermentation, butyrate, has been hypothesized to 
be able to induce a hyper-induction of Wnt, initiating apoptosis (Bordonaro, et al., 2008).  The 
initiation of the apoptotic cycle then provides a secondary, “rescue” mechanism for regulating 
and controlling unregulated tumorigenic cell growth.  This hyper-induction has also been shown, 
through the Notch signaling pathway, to cause post translational modifications of β-catenin.  
This is hypothesized to inhibit cell proliferation by halting the stem cell and progenitor cell 
population in the G0 phase of the cell growth cycle (Kwon, et al., 2011).  
 The purpose of the studies included in this thesis is to assess the inhibitory effect of 
various resistant starches on the genetic mechanisms underlying CRC.  The hypothesis 
underpinning these studies is that resistant starch and the microbial metabolic products generated 
from resistant starch will regulate the Wnt signaling pathway, controlling proliferation of normal 
and pre-neoplastic (initiated) colonic epithelial cells. 
 
Thesis Organization 
 This thesis examines the inhibitory effect of cooked diets containing high concentrations 
of resistant starches (ARxGUAT, GUAT, HA7, OS-HA7, and SA-HA7) or highly digestible 
starches (AR and a commercially available cornstarch) on the canonical Wnt signaling pathway 
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of azoxymethane-induced rat and mouse model using β-catenin as a primary target gene along 
with other genes and proteins that are involved in colorectal carcinogenesis and serve as 
indicators of CRC.  
 I will first review the pertinent literature to examine background concepts and the 
formulation for hypotheses on which these studies are based.  I will then report the results of an 
investigation evaluating the effects of diets containing starch derived from one of three corn lines 
(AR, ARxGUAT, and GUAT) and their effects on a pre-neoplastic lesions, ACF (work 
conducted prior to my arrival at Iowa State University), and mRNA expression of genes of the 
Wnt signaling pathway with my genetic studies contributing to preexisting lesion studies.  In this 
study, Dr. Linda Pollak and Dr. Duvick in the Department of Agriculture in Iowa State 
University carried out all corn line crossings.  Dr. Yinsheng Zhao assisted with the starch 
processing, set up the animal model, and analyzed the efficacy of resistant starch on a putative 
preneoplastic lesion.  I analyzed the efficiency of resistant starches on the mRNA expression of 
key genes in the Wnt signaling pathway of both full-thickness colonic tissue and cells of the 
colonic epithelial surface and crypt.  I also wrote the manuscript for this collective work.  In a 
second manuscript, I will report the effects of diets containing one of three forms of resistant 
starch (HA7, OS-HA7, and SA-HA7) or control starch on the expression of Wnt signaling genes.  
Dr. Jay-Lin Jane, Michael Reed, and Yongfeng Ai in the Department of Food Science and 
Human Nutrition in Iowa State University modified the high-amylose 7 resistant starch to both 
OS-HA7 and SA-HA7 and analyzed the resistant starch content of the diets in both studies.  
Bridget Nelson, also of the Department of Food Science and Human Nutrition, and I collectively 
set up the animal model for this study under the supervision of Dr. Diane Birt and Dr. Elizabeth 
Whitley of the Department of Food Science and Human Nutrition and Department of Veterinary 
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Pathology, respectively.  Reed Faldet, Kylie Thompson, Dana Pralle, and Rachel Scieszinski 
assisted with animal care.  I analyzed the effectiveness of resistant starches on the mRNA 
expression of key genes in the Wnt signaling pathway from colonic crypt epithelium.  I also 
wrote the manuscript for this collective work.  At the end of the dissertation, a general 
conclusion will be presented.  
 
Literature Review 
Colorectal Cancer (CRC) 
 Colorectal cancer is a leading cause of cancer deaths in the world and is the third most 
prevalent cancer in the United States, affecting men and women equally.  The American Cancer 
Society estimates 102,480 new cases of colon cancer and 40,340 new cases of rectal cancer in 
2013.  They also estimate that, this year alone, CRC will cause 50,830 deaths (American Cancer 
Society, 2013).  Statistics from a 2008 study by the World Health Organization show that the 
highest rates of incidence of colorectal cancer are observed in Australia, New Zealand, and 
Western Europe with the lowest rates observed in Africa and South-Central Asia 
(GLOBOCAN). The highest rates of mortality are in Central and Eastern Europe with the lowest 
mortality rate being in Middle Africa (GLOBOCAN).  Center, et al. showed that CRC incidence 
rates are on the rise in countries that are transitioning to becoming fully economically developed 
countries, affecting both males and females with equal incidence (Center, et al., 2009).  This 
research, based on data from 1983-87 and 1998-2002, also reported a stabilization of CRC 
incidence among fully developed countries. 
 Colorectal cancer develops in a series of molecular steps reflected by alterations in 
morphology along a continuum extending from normal to preneoplastic to neoplastic (benign, 
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then malignant) and, sometimes, metastatic lesions.  Cancer of the colon develops as a 
consequence of uncontrolled cell growth by the cells of the epithelial lining of the colon or 
rectum.  This neoplasm develops in the epithelial lining of the colon or rectum, with most 
cancers starting as benign polyps, sometimes eventually progressing to malignant 
adenocarcinomas, and may grow through some or all of these other layers of tissue that form the 
wall of the colon.  Once this neoplasm invades through the epithelial lining and migrates to the 
draining lymph node or another organ, it is classified as a metastasis (Falterman, et al., 1974). 
 Colorectal cancers can arise through either a sporadic genetic mutation or a hereditary 
genetic condition.  About 94% of CRCs arise through a sporadic mutation, while approximately 
6% of CRCs are inherited (Coleman and Tsongalis, 2009).  Familial adenomatous polyposis 
(FAP), the predominant form of the inherited CRCs, is characterized by polyp formation in the 
colon and upper gastrointestinal tract.  Individuals with this condition may also experience 
desmoid tumors (Kohler, et al., 2009).  In both sporadic CRC and FAP, the underlying cause is a 
mutation in the Adenomatous Polyposis Coli (APC) gene, which is located on human 
chromosome 5q21 (Groden, et al., 1991; Shibata, 1997; Kohler, et al., 2009).  Up to 80% of all 
sporadic colorectal carcinomas have been shown to have a loss-of-function mutation in the APC 
gene (Schneikert and Behrens, 2007).  APC is known as a tumor-suppressor gene, so a mutation 
that results in inactivity of the gene product would allow progression toward malignancy 
(Segditsas and Tomlinson, 2006; Schneikert and Behrens, 2007).  The disease may then progress 
through the stages of dysplasia, adenoma, adenocarcinoma, and, finally, in fulminant disease, 
distant metastasis (Nambiar, et al., 2003). 
 While familial adenomatous polyposis (FAP) is rare, among the documented cases, there 
are many genetic variations due to the many possible mutations of APC (Dienz and Clevers, 
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2000; Reya and Clevers, 2005).  The most common APC mutation is a deletion of the nucleotide 
sequence, AAAAG, beginning at codon 1309, a defect which is present in 10% of all FAP cases 
(Giles, et al., 2003).  Many of these mutations affect only one allele, resulting in loss of control 
of cell proliferation that allows the development of one or more colonic polyps, non-malignant 
neoplasms also called adenomas.  It is not until the second allele becomes mutated that the loss 
of FAP function allows the development of a cancerous lesion.  Adenomas can lead to cancer if 
left untreated, due to the accumulation over time of this critical second mutation (Giles, et al., 
2003; Reya and Clevers, 2005; Segditsas and Tomlinson, 2006; Schneikert and Behrens, 2007; 
Kohler, et al., 2009).  The progression toward cancer starts with crypts of the colon undergoing 
hyperplasia. A lesion seen in the epithelium in association with CRC, aberrant crypt foci (ACF), 
is believed to occur commonly in colon cancer patients and may serve as a precursor lesion for 
CRC (Papanikolaou, et al., 1998).  Preventive measures for CRC currently include surveillance 
measures, such as colonoscopy, to identify and remove pre-malignant lesions.  (Schneikert and 
Behrens, 2007).   
 
Mechanism of Colon Cancer 
 Both sporadic and hereditary forms of colon cancer are believed to follow the same 
progression from ACF to metastatic carcinoma (Coleman and Tsongalis, 2009).  There are three 
primary molecular pathways through which this progression occurs.  They are the Chromosomal 
Instability Pathway (CIN), the Microsatellite Instability Pathway (MSI), and the CpG Island 
Methylator Pathway (CIMP).  The CIN pathway is the most common pathway for colon cancer 
progression.  This pathway is characterized by gains and losses of large chromosomal regions 
and neoplastic cells commonly have allelic loss (Figure 1).   
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Figure 1. Chromosomal Instability Pathway (Walther et al 2009). 
 
Inactivation of tumor-suppressor genes like APC or p53 begins this stepwise progression toward 
colorectal carcinogenesis.  Under this circumstance, normal epithelium will undergo de-regulated 
proliferation and aberrant crypt foci (ACF) may develop.  The inactivation of APC results in 
inactivation in the Wnt signaling pathway.  This inactivation of the Wnt pathway leads to 
translocation of β-catenin into the nucleus where it progressively accumulates and initiates 
transcription activation of key genes needed for cell proliferation, differentiation, and migration 
(Van de Wetering, et al., 2002).  β-Catenin thus plays an important role in enhancing neoplastic 
progression toward early adenoma.  De-regulation of the Wnt signaling pathway is not, however, 
the only mechanism that affects the progression toward carcinogenesis.  Mutations in the K-ras 
gene, an oncogene frequently activated in cancer, occur during ACF formation shortly following 
the APC inactivation and also support progression not only to early adenomas, but also to 
intermediate adenomas (Coleman and Tsongalis, 2009).  Inactivation of SMAD2 and SMAD4, 
two tumor-suppressor genes, then cause these intermediate-stage adenomas to progress to late-
stage adenomas (Sancho, 2007).  Adenomas typically develop additional genetic mutations, with 
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those in p53 and DCC (deleted in colon cancer) being most frequent (Fearon and Jones, 1992).  
Defects in these additional tumor-suppressor genes provide a further mechanism for progression 
to malignancy.  Mutations in E-cadherin will further result in a metastatic carcinoma (Coleman 
and Tsongalis, 2009).  
 The Microsatellite Instability pathway (MSI) is characterized by defects in the DNA 
mismatch repair proteins.  A loss of function in any one of these proteins (MLH1, MSH2, 
MSH6, and PMS2) results in a large number of genetic mutations within any one of the genes 
discussed above and several others affecting the progression of cancer (Coleman and Tsongalis, 
2009). 
 The CpG Island Methylator Phenotype pathway (CIMP) is characterized by abundant 
CpG methylation of DNA molecules of neoplastic cells.  This hypermethylation leaves genes 
unable to be transcribed or proteins unable to bind to DNA.  The methylation can silence genes 
which regulate cell proliferation, differentiation, and migration.  The methylation can also 
inactivate genes which are classified as tumor suppressors, leaving them unable to function 
properly.  CIMP does appear to be able to interact with the Wnt signaling pathway and to 
methylate needed regulators of the Wnt pathway (Coleman and Tsongalis, 2009). 
 Together, these three main molecular mechanisms, CIN, MSI, and CIMP, demonstrate 
the stepwise progression of colorectal carcinogenesis and the important role genetic mutations 
play in each model.  While the chromosomal instability pathway may be the most common, all 
three mechanisms are important in understanding colorectal cancer. This pathway also underlies 
the Wnt signaling pathway, which is the focus of the research presented in this thesis. 
 
Wnt Signaling Pathway 
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 The Wnt pathway is involved in many different processes of mammalian development 
including cell proliferation, differentiation, and epithelial-mesenchymal interaction.  These 
processes contribute to the development and maintenance of many tissues and organs (Moon, et 
al., 1997; Smalley and Dale, 1999).  The Wnt pathway controls many of these activities by 
regulating and acting on the stem cell populations in each of these tissues (Reya and Clevers, 
2005; Nusse, 2008).  Because the Wnt signal acts on the stem cell populations, de-regulation of 
this pathway has the potential to lead to cancer.  The canonical Wnt pathway has been implicated 
in initiation and progression of tumors (Polakis, 2000; Dimitriadis, et al., 2001).   
 The canonical pathway is a complex cascade of events that ends in the translocation of β-
catenin into the nucleus and it's binding to the LEF/TCF complex, which then initiates 
transcription of Wnt-target genes.  The cascade is initiated when one of the many secreted Wnt 
glycoproteins binds to a Frizzled transmembrane receptor.  There are 16 recognized Wnt 
glycoproteins, with many of them partially tissue-specific (Polakis, 2000; Huelsken, 2002).   
 Ligation of Frizzled (Fz) causes Axin to bind to and phosphylorate Dishevelled (DSH).  
These two proteins bind to GSK3-β, which, in an unbound state is able to bind to β-catenin and 
signal it for degradation.  This binding thus allows β-catenin to accumulate in the cytoplasm and 
translocate to the nucleus (Polakis, 2000; Huelsken, 2002).  Once in the nucleus, β-catenin binds 
to the LEF/TCF complex and transcribes many target genes (Cadigan and Nusse, 1997; Cadigan 
and Liu, 2005).  These targets include Axin 2, C-myc, and TFRC, which function in assisting to 
stabilize β-catenin, regulating chromatin structure, and in the uptake of cellular iron, 
respectively.  Each of these target genes is required for cell proliferation and differentiation and 
their expression will further enhance the rate of proliferation of cells (Leung, et al., 2002; Rohrs, 
et al., 2009).  This becomes a positive feedback loop with target gene expression allowing cells 
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to build up and those cells to accumulate β-catenin in the cytoplasm, which results in a nuclear 
translocation and those target genes being transcribed. 
 
Figure 2. Wnt signaling pathway in an inactive (off) and active (on) states (Jamieson, 2012). 
  
 In the non-canonical pathway, β-catenin does not accumulate in the nucleus because it is 
degraded in the cytoplasm.  In this cascade, Wnt proteins do not bind to the Frizzled receptors.  
This lack of binding keeps Dishevelled from being phosphylorated which allows it, as well as 
Axin and APC, to bind to β-catenin.  The APC/β-catenin complex then recruits GSK3-β to bind 
and phosphylorate β-catenin (Holcombe, et al., 2002; Reya and Clevers, 2005).  Proteasomes 
carry out the actual degradation process (Leung, et al., 2002).  Because of this phosphyloration, 
β-catenin is degraded and cytoplasmic accumulation is prevented.  Subsequently, Wnt target 
genes are not transcribed and cells are not stimulated to divide, due to lack of a positive growth 
signal (Dienz and Clevers, 2000; de Sousa, et al., 2011).   
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 In the colorectal epithelial model, the Wnt signal acts on the stem cell populations of the 
crypts.  The signal instructs the stem cells to divide and maintains proliferation.  The daughter 
cells migrate up the crypt wall, pushing the older cells to the top of the crypt where they are 
sloughed into the lumen as they become effete.  The Wnt signal only acts on deep crypt 
populations, which comprise the stem cells and a few progenitor cells (Kosinski, et al., 2007; 
Hirata, et al., 2013).  In a canonical or de-regulated state, the deep crypt cells continue to 
proliferate, continually moving up the crypt wall causing cells to build up.  Two important 
proteins in this pathway are APC and β-catenin.  These two proteins interact in the normal cells, 
with APC controlling how often cells divide and how the cell attaches to other cells within a 
tissue and β-catenin regulating the cell-to-cell adhesion and gene transcription.  The genes 
encoding these two proteins contain the majority of the mutations that result in de-regulation of 
epithelial growth (Morin, et al., 1997; Schneikert and Behrens, 2007). 
β-Catenin 
 β-catenin, coded by the CTNNB1 gene, is a cadherin-binding protein as well as a 
transcriptional activator when joined with TCF (Morin, et al., 1997; Feng Han, et al., 2006).  β-
catenin has important roles in cell adhesion and signal transduction (Huber and Weis, 2001).  It 
stimulates proliferation through modulation of the expression of certain target genes.  β-catenin 
has an amino terminal domain of 149 amino acids with a central domain of 515 amino acids 
counting 12 armadillo repeats (20 amino acids each) and finally a C-terminal domain with 108 
residues.  β-catenin is able to bind to APC via the armadillo repeat domain and has 
phosphorylation sites on Ser45, 41, 37, and 33 of the N-terminal domain that become available 
after binding for GSK3-β to phosphorylate (Huber and Weis, 2001; Kohler, et al., 2009).  APC 
may be unable to bind to β-catenin if APC is mutated or if β-catenin is mutated.  Both defects 
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result in a de-regulation of the Wnt signal, causing β-catenin to build up in the nucleus which 
may lead to cancer (Morin, et al., 1997).  This build up in the nucleus is greatest in the epithelial 
colonic crypts with a decreasing gradient of β-catenin as the cells migrate up the crypt wall due 
to lack of active signal acting on these cells (Pinto and Clevers, 2005; Kosinski, et al., 2007).  
While APC mutations are very common in CRC, in tumors without APC mutations, a β-catenin 
mutation is almost always present and occurs in 15% of all CRC cases and commonly occurs in 
the central domain causing a deletion of about four of the repeat sequences (Shibata, 1997; 
Polakis, 1999; Polakis, 2000).  It is not the deletions themselves that support the development of 
CRC, but disruption of the binding sites as APC binds to β-catenin between repeat 3 and 4 
causes a deletion of these repeats, resulting in an inability of APC to bind Axin (Polakis, 1999).   
 Many studies have shown that increased β-catenin expression promotes carcinogenesis in 
a dose-dependent manner.  However, a recent study reports that, paradoxically, abundant over-
expression of β-catenin may actually slow proliferation of the colonic crypt epithelium, as these 
cells fail to express Ki-67, a nuclear protein needed for proliferation.  This loss of Ki-67, in a 
mechanism still unknown, prevents proliferation of cells containing high levels of β-catenin and, 
under the conditions of an initiated cell, would slow any progression by the crypt population 
toward CRC (Hirata, et al., 2013).  
Adenomatous Polyposis Coli (APC) 
 APC is a tumor suppressor gene, located on 5q2, which acts as a downstream regulator of 
the Wnt pathway.  It regulates cellular levels of β-catenin by targeting it for degradation via the 
ubiquitin pathway (Dimitriadis, et al., 2001; Kohler, et al., 2009).  APC has binding sites for 
Axin and β-catenin with a segment located between the 20R2 and 20R3 (20 amino acid repeat 2 
and 3 respectively), which spans amino acids 1404-1466, being most important for degradation 
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of β-catenin (Segditsas and Tomlinson, 2006; Kohler, et al., 2009).  A mutation in this region 
would result in the inability to degrade β-catenin.  APC also plays roles in chromosomal 
segregation and any defects would thus promote cancer progression (Schneikert and Behrens, 
2007). 
 Approximately 85% of all colorectal cancers, both sporadic and hereditary, show an 
inability of APC to function and such tumors also have high levels of β-catenin and loss of APC-
mediated regulation (Shibata, 1997; Dienz and Clevers, 2000).  Familial adenomatous polyposis 
(FAP) is a hereditary colorectal cancer that is characterized by large numbers of colon polyps 
that arise because patients are defective in one APC allele (Reya and Clevers, 2005).  Once the 
second allele becomes defective, cancerous lesions start to form due to complete lack of APC 
being able to regulate CRC via the Wnt pathway. 
Transferrin Receptor Protein (TFRC) 
TFRC is a target of the Wnt signaling pathway required for iron delivery from transferrin 
to cells.  TFRC protein is necessary for proliferation as cell growth cannot occur without iron.  
Because of this, TFRC mRNA expression is increased when cell proliferation is increased, in 
order to accept more iron from transferrin to satisfy growth needs, and is expressed in high 
quantities in proliferating or cancerous cells (Ryschich, et al., 2004; Rohrs, et al., 2009). 
Axin2  
The protein, Axin 2, functions to organize a complex between APC, β-catenin, GSK3-β 
and conductin.  This complex then is able to promote the phosphyloration of β-catenin which 
marks it for degradation.  Without this complex and the ability of Axin 2 to bind to these 
multiple proteins, β-catenin would not be able to be regulated (Jho, et al., 2002; Leung, et al., 
2002).  This negative feedback pathway is then able to regulate the Wnt pathway. In this way, 
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Axin 2 functions as a tumor suppressor as it negatively regulates this growth stimulatory 
pathway (Polakis, 2000).   
c-Myc 
c-Myc is a target of the Wnt signaling pathway and is itself a transcription factor, meaning 
that it can then initiate transcription of other genes that are indirect targets of the Wnt pathway.  
Up-regulation of c-Myc results in cellular proliferation or activation (Rohrs, et al., 2009).  c-Myc 
in some instances acts as a repressor by recruiting histone deacetylases (Rohrs, et al., 2009). 
Wnt 8a 
All Wnt proteins are ligands that bind with certain affinities to any one of the seven 
Frizzled receptor proteins.  Wnt 8a has been shown to demonstrate expression differences in 
normal compared to tumor colonic tissue (Bouillet, et al., 1996). 
Wnt Inducible signaling pathway protein 1(WISP-1) 
The WISP-1 protein is another target of the Wnt signaling pathway.  Its expression is 
greatly increased in neoplastic cells and promotes tumor growth by inducing morphological 
transformation and cellular saturation (Xu, et al., 2000). 
Secreted Frizzled-Related Protein 4 (SFRP4) 
SFRP4 is a secreted protein that is able to bind to both the Frizzled receptor and Wnt 
ligand via the N-terminal cysteine-rich domain.  This binding prevents the Wnt ligand from 
binding to the receptor protein and blocks the signal from continuing along the pathway (Feng 
Han, et al., 2006).  Colorectal tumors commonly display a hypermethylated promoter region of 
the SFRP4 gene which is enough to silence the gene and prevent any suppression of the Wnt 
pathway (Feng Han, et al., 2006).  Expression of SFRP4 in colorectal cancer is controversial as 
some researchers have found no differences between expression in normal and carcinogenic 
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colonic tissue while others have found significant differences between these two states (Suzuki, 
et al., 2004; Feng Han, et al., 2006; Huang, et al., 2010). 
 Understanding the function of each of these Wnt pathway proteins, in both normal and 
initiated states, is necessary when investigating how to regulate and maintain a normal non-
initiated state. 
 
Microbiota of the Colon 
 The colonic microbiota, in response to changes in the environment, including diet, greatly 
affects proliferation and differentiation of the colorectal mucosa through the production of 
various metabolically active compounds. The human microbiota of the colon is home to 10 times 
as many bacterial cells than there are human cells in the body.  Many other organisms, such as 
archaea, viruses, parasites, and/or fungi also call the human gut home (Moschen, et al., 2012).  
The microbiota contains over 1,000 distinct species of bacteria (Simon and Gorbach, 1984; Qin, 
et al., 2010).  Many of these species are anaerobic and together have 100- to 200-fold more genes 
than the human genome (Cummings and Macfarlane, 1997; Ashida, et al., 2012; Moschen, et al., 
2012).  The colonic microbiota is able to break down carbohydrates normally excreted by the 
host into short-chain fatty acids (SCFAs), gases, and organic acids.  These SCFAs are absorbed 
and used by many human tissues, such as epithelial cells of the colon and liver, as energy sources 
(Cummings and Macfarlane, 1997; Jacobasch, et al., 1999).  Through this "salvage pathway", the 
colonic microbiota can have large impacts on host health (Moschen, et al., 2012).  Based on the 
products of fermentation, some genera of the colonic microflora, Bifidobacterium and 
Lactobacterium, for instance, have health-promoting properties, while others, such as 
Bacteroides and Clostridium, have health-damaging properties (Wollowski, et al., 2001; 
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Oberreuther-Moschner, et al., 2004; Lim, et al., 2005).  Harmful effects include diarrhea, 
infections, and carcinogenesis, while health-promoting effects include increased immune 
function, improved digestion and absorption of nutrients, and synthesis of vitamins (Gibson and 
Roberfroid, 1995; Grabitske and Slavin, 2009).  This large impact of the microbial community 
on the colon through the salvage pathway, and corresponding end-products of fermentation by 
individual species, greatly influences colorectal tumorigenesis formation and progression 
(O'Keefe, et al., 2009).   
 The intestinal microbial communities are relatively stable within an individual across 
time, but can be dramatically impacted by the environment, including diet and antibiotic therapy 
(Gill, et al., 2006; Jalanka-Tuovinen, et al., 2011; Birt and Phillips, 2013).  This community is 
very sensitive to population and environmental changes, as a metabolic end-product of one 
species may serve as a nutritional source for another.  In this way, altering one species may very 
quickly affect many other species of bacteria (Gibson and Roberfroid, 1995).  These bacteria 
thrive on fermentable carbohydrates and other ingesta that escape small intestine digestion, with 
bacterial populations changing as food sources change.  Altering microbial food sources may 
provide a means of shifting fermentation products away from those that do not benefit the hosts' 
health and toward those that do. 
  
Diet and Lifestyle 
 Many studies have centered on the central theme of diet and lifestyle factors significantly 
impacting the incidence of colorectal cancer.  It is not just lifestyle: race and gender also impact 
responses to various diet components.  One study performed in Nashville, Tennessee looked at 
many factors of lifestyle in relation to colorectal polyp formation in over 6,000 participants (Fu, 
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et al., 2012).  This study found that elevated risk of polyp formation was associated with 
smoking, obesity, and red meat and alcohol consumption, while reduced risk of polyp 
development was associated with regular NSAID use and high daily intakes of fiber, vitamin A, 
and calcium (Wu, et al., 1987; Oberreuther-Moschner, et al., 2004; Fu, et al., 2012).   Other 
studies have shown that various healthy behaviors, such as regular physical exercise and eating 
large amounts of fruits and vegetables, also relate to a decreased risk of colorectal cancer 
(Scharlau, et al., 2009).  Not all studies have agreed on every aspect of diet and lifestyle in 
relation to risk of colorectal carcinogenesis.  There are, however, two widely accepted colorectal 
diet associations: dietary fiber is a widely accepted inhibitory factor, while red meat is facilitator 
of colorectal carcinogenesis. 
 Dietary fiber has been widely accepted as a prebiotic that is protective against CRC.  
Many studies, though, have reported varying results about the actual benefits of natural dietary 
fibers and under what conditions they are active.  The recommended intake should be at least 25-
30 g/day, with the average human on consuming half that amount.  The amount of fiber 
consumed in each study also highly impacts the resulting conclusions of dietary fiber's effects on 
CRC, risk with more fiber shown to be more protective (Mai, et al., 2003). Dietary fiber is the 
indigestible portion of food from the plant and includes many types of resistant starch.  Studies 
agree in general that dose, nature of dietary fiber, and frequency and duration of consumption 
matter when studying the effects on CRC (Nofrarias, et al., 2007; Mathers, et al., 2012).  
Findings from a 26-year-long study suggest that fiber from green salads has no effect on risk of 
CRC, while cooked green vegetables, tomatoes, and legumes have a protective effect 
(Tantamango, et al., 2011).  Grain fibers did not show any statistically significant associations, 
although participants in this study had a low consumption of eating grains (Tantamango, et al., 
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2011).  Another large study involving 283,222 women with an average follow up of 8 1/2 years 
showed no correlation between fiber and CRC.  However, the maximum dietary fiber intake in 
any of the participants was only 16.7 g/day.  This low level of fiber intake may be responsible for 
the no- to low-inverse relationships reported by other studies as it is well below the 
recommended daily intake. (Schatzkin, et al., 2007). 
 While dietary fiber consumption has been recommended for CRC prevention, high 
consumption of red meat has been discouraged (Pierre, et al., 2003; Fu, et al., 2012).  As with 
dietary fiber, many studies report varying results with the amount of meat consumed, preparation 
method, level of doneness, and frequency of consumption affecting CRC risk.  A study 
conducted in Australia with 1,200 participants aged 40-80 answered a questionnaire on their 
meat consumption and all aspects of cooking/consuming this meat as well as all other lifestyle 
factors in relation to polyp formation/removal and CRC occurrence.  The study found no 
significant relation to any meat consumption levels or specific cooking practices to an increased 
risk of CRC (Tabatabaei, et al., 2011).  A meta-analysis of 17 publications on meat consumption 
in relation to CRC risk showed that an increase of 100g per day of any meat results in a 12-17% 
increased risk of CRC (Sandhu, et al., 2001).  These findings are based on only 17 studies, of 
which many had co-variables, making it challenging to determine if the effects seen in those 
studies were due to meat consumption alone or the interactions between variables (Sandhu, et al., 
2001).  These studies also had many issues with quantifying intake from questionnaires and 
classifying cooking doneness without actually measuring the doneness of the prepared meat, as 
perception may vary from one participant to another. 
 Evaluating effects of diet on CRC has proven challenging, but as more studies are 
completed, dietary recommendations for prevention of CRC will be strengthened.  Diets rich in 
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meat should be avoided while those with ample amounts of vegetables, fruits, and dietary fibers 
should be sought after.  Physical exercise is recommended while consuming large quantities of 
alcohol is not.  Maintaining a healthy weight also reduces risk of CRC.  The amount of food 
consumed and the way in which it was cooked also matters when evaluating a person's CRC risk 
(Wu, et al., 1987; Scharlau, et al., 2009). 
  
Starch 
 Starch is the major component of grains and is routinely used in the food industry for 
cereals and pastas.  It is synthesized in the leaves of green plants and used as a storage site for 
energy (Jane, et al., 1994; Han and Hamaker, 2001).  Starch is made up primarily of two glucose 
polymers, amylose and amylopectin.  Amylose is mainly linear α-(1, 4)-linked D-glucopyranosyl 
units with less than 1% glycosidic linkages.  It makes up about 15 to 30% of normal starch, but 
can be up to 85% of some inbred varieties of high amylose corn starch (Tharanathan, 2002).  
Amylopectin, on the other hand, is extensively branched and contains α-(1, 4)-linked D-
glucopyranosyl units joined through α-(1, 6) linkages (Delcour, et al., 2010).  Amylopectin 
comprises about 20 to 45% of normal starch and has a semi-crystalline structure unlike the 
amorphous structure of amylose (Tharanathan, 2002).  Starches naturally occur as granules, but 
the dimensions and morphologies vary depending on the plant origin.  Corn starch granules 
typically have a “Maltese cross” appearance when viewed under polarized light (Figure 2) 
(Baldwin, et al., 1994; Cummings, et al., 1996; Delcour, et al., 2010). 
 Gelatinization is the process of transforming the starch granules, with an adequate 
amount of water, into a viscoelastic paste.  The process of heating the granules in water causes a 
swelling of the granule and turns the crystallized structure into a more amorphous form 
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(Tharanathan, 2002).  Subsequent cooling, called retrogradation, allows the amylopectin and 
amylose chains to recrystallize (Delcour, et al., 2010).  Many factors impact the rate of 
gelatinization and retrogradation, such as type of plant starch, amylopectin and amylose contents, 
rate of heating and cooling, and presence of non-starch components (Garcia-Alonso, et al., 1999; 
Rocha, et al., 2011). 
 
Figure 2. Starch viewed under polarized light showcasing a typical “Maltese cross”. 
 
 In order for animals to derive the energy stored in starch, they must be capable of 
breaking down the α-1, 4 bonds.  This is called enzyme hydrolysis and carried out by 
glucoamylases which are found in saliva and pancreatic secretions of humans and animals and 
also are secreted by bacteria (Marin-Navarro and Polaina, 2011).   
 Resistant starch is starch or a fraction of starch that is not hydrolyzed by enzymes in the 
digestive tract and is instead available for fermentation by the microflora in the colon (Englyst, 
1986; Cummings, et al., 1996).  The result of this fermentation is the production of short chain 
fatty acids (SCFAs), gases, and other organic acids (Grabitske and Slavin, 2009).  There are 
currently five types of resistant starch with classification based on structures and resistant 
content (Themeier, et al., 2005).  Type 1 (RS1) is physically inaccessible to enzymatic 
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degradation by α-amylase because it is blocked by the cell wall.  The starch granules only 
become accessible to enough water to fully gelatinize when the cell wall is broken down 
(Jacobasch, et al., 1999; Themeier, et al., 2005).  Resistant starch type 2 (RS2) is a naturally 
occurring granular starch found in raw potatoes, peas, and green bananas.  It has a 
semicrystalline structure that is able to prevent or to slow enzymatic digestion by α-amylases 
(Themeier, et al., 2005; Jiang, et al., 2010).  However, when RS2 is cooked, it loses the 
crystalline structure and becomes completely amorphous, allowing slow, but complete digestion 
(Tharanathan, 2002; Hasjim, et al., 2010).  Type 3 RS (RS3) is retrograded starch resulting from 
heating and then cooling the starch molecules.  This type of resistant starch has a crystalline 
structure that is able to undergo enzymatic break-down by microbial fermentation, but not by 
mammalian digestive enzymes (Jacobasch, et al., 1999; Ze, et al., 2012).  Starches that can be 
retrograded to form RS3 have high amylopectin content with chains that are long enough to 
produce stable crystalline structures (Tharanathan, 2002).  Resistant starch type 4 (RS4) is a 
chemically modified starch that has a decreased accessibility of the enzymes to hydrolyze the 
granules (Jiang, et al., 2010).  RS type 5 (RS5) is a newly developed amylose-lipid complexed 
starch.  This amylose-lipid complex has been shown to resist digestion as the lipids block the 
chains from being accessed by enzymes (Hasjim, et al., 2010; Jiang, et al., 2010). 
 The resistance to digestion of resistant starch has many potential health benefits, serving 
as a prebiotic.  It reduces postprandial plasma-glucose and insulin responses, which are 
components of the pathogenesis of diabetes.  Because of lowered blood glucose levels, rates of 
cholesterogenesis, lipogenesis, and lipolysis are also reduced (Hasjim, et al., 2010; Lattimer and 
Haub, 2010).  Consequently, ingestion of resistant starches is believed to have the ability to 
reduce the occurrences of cardiovascular diseases and some forms of diabetes.  Dietary resistant 
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starch may also reduce obesity by lowering the total energy intake.  Resistant starch stays in the 
digestive system longer and increases satiety, which may reduce food intake (Raben, et al., 
1994).  However, resistant starch is a poor source of metabolic energy, which may cause energy 
to be obtained from other sources, such as other foods, or retrieved from the storage depots in 
adipose tissue (Raben, et al., 1994). 
 Resistance starch not only has an effect on the glucose-insulin system, but also has been 
shown to prevent colon pre-neoplastic lesions in animal models (Clausen, et al., 1991).  The 
SCFAs that are released as byproducts of microbial metabolism have been shown to induce 
proliferation by cells at the crypt base and to inhibit proliferation at the luminal surface, which 
allows for tightly controlled epithelial growth (Jacobasch, et al., 1999).  Some SCFAs also 
inhibit DNA synthesis and arrest cell growth in the G1 phase of the cell cycle in neoplastic cells, 
preventing any further cell growth (Jacobasch, et al., 1999). 
 Manipulating the variation of SCFAs present in the colon, through host consumption of 
resistant starch, can provide a highly valuable means to maintain normal colonic cell growth.  
 
Short Chain Fatty Acids (SCFAs) 
 Short chain fatty acids are by-products of the bacterial fermentation process.  The pattern 
of SCFA production is related to the bacterial species composing the microbiome and the 
composition of the partially digested ingesta that enter the large intestine (Christian, et al., 2003; 
Duncan, et al., 2004).  Acetate, propionate, and butyrate are the primary microbial fermentation 
by-products found in fecal and cecal samples. Butyrate and propionate have been shown to have 
beneficial health properties, while acetate has been shown to be the most abundant (Cummings 
and Macfarlane, 1997; Wolin, et al., 1999).  Other SCFAs are present, but are not excreted in the 
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feces, as they apparently become sources of nutrition for other anaerobic bacteria or are 
transferred to the host (Duncan, et al., 2004). 
 Fermentation of plant polysaccharides such as resistant starch is expected to cause an 
increase in the stool mass and to reduce the transit time of the feces through the digestive system.  
Both of these factors are shown to reduce the potential exposure of colonocytes to mutagens and 
carcinogens through dilution (greater mass) and a shorter exposure time (Fung, et al., 2012), 
thereby reducing DNA damage and the accumulation of cancer-potentiating mutations.   
Increased SCFA production was also found to decrease luminal pH, which causes a decrease in 
7α-dehydroxylase, a bile acid breakdown enzyme.  If this enzyme remained active, secondary 
bile acids are formed that inhibit butyrate from properly regulating cell proliferation (Jacobasch, 
et al., 1999; Lesmes, et al., 2008). 
 While acetate and propionate are primarily metabolized by various body tissues, butyrate 
predominantly stays in the colon, where it is metabolized by the colonic epithelium (Bourquin, et 
al., 1996).  Butyrate is able to induce cell differentiation, promote growth and proliferation of 
normal tissue of the colon while inhibiting cancerous cell growth (Clausen, et al., 1991).  While 
the other SCFAs leave the colon, butyrate moves to the crypt base where it acts on the epithelial 
cells, controlling transcription expression and activity of genes and proteins of the apoptotic 
pathway.  Butyrate is able to inhibit DNA synthesis of neoplastic cells by inhibiting histone 
deacetylase activity, causing them to undergo apoptosis (Nofrarias, et al., 2007; Fung, et al., 
2012).  Many studies have looked at butyrate and its effects in both animal and human studies 
with a large amount of those studies demonstrating beneficial properties of butyrate.  Increasing 
concentrations of butyrate in the colonic tissue could possibly provide an excellent approach, for 
future preventative medications, in inhibiting cancerous cell growth. 
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Animal Models of Colorectal Carcinoma 
 Selection of an appropriate animal model is crucial for every study, especially when 
investigating the initiation and progression mechanisms that underlie the development of CRC.  
Selection of an appropriate mouse model of CRC is dependent upon the specific mechanism 
under investigation in order to provide the best laboratory correlate of the human disorder.  
Genetically modified mouse models like APCmin/+ mice are inappropriate for studying sporadic 
colon cancer, especially when studying genetic variations caused by diet or lifestyle factors, but 
are better suited and more commonly used  to study hereditary CRC like FAP (Taketo and 
Edelmann, 2009; De Robertis, et al., 2011).  Chemically induced CRC models such as A/J mice 
are used to studying sporadic CRC (Hung, et al., 2010). 
 Azoxymethane (AOM) is a commonly used carcinogen for specific induction of colon 
cancer.  Azoxymethane is a metabolite of 1, 2-dimethylhydrazine (DMH) and is a specific colon 
carcinogen (Hirose, et al., 2003; Bissahoyo, et al., 2005).  The carcinogen, AOM, does not 
interact with DNA directly but is metabolized by cytochrome P450 enzymes, which then allows 
hydroxylation of the methyl group of AOM (Chen and Huang, 2009; De Robertis, et al., 2011).  
This hydroxylation results in methylazoxymethanol which breaks down into formaldehyde, a 
highly reactive alkylating agent, causing alkylation of guanine to O6-methylguanine or O4-
methylthymine.   The change of guanine to either of these, result in an inappropriate switch of 
DNA nucleotide pairing from a C:G to A:T with O6-methylguanine binding to thymine and O4-
methylthymine binding to adenine.  These mutations can occur in any gene, such as k-ras, with 
many mutations having the capacity to initiate tumorigenesis (Hirose, et al., 2003; Chen and 
Huang, 2009; Cheung, et al., 2010).  The polysaccharide, DSS, is a pro-inflammatory reagent 
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and commonly used in combination with AOM administration (Tanaka, et al., 2003; Suzuki, et 
al., 2006; Laroui, et al., 2012).  There is a common procedure of using a single AOM injection 
and DSS in the water for up to 20 weeks to mimic colitis-driven tumor development, but this 
requires a lengthy study period and results in low tumor multiplicity. (Tanaka, et al., 2003; 
Suzuki, et al., 2006). 
 Strains of mice react differently to each of these chemicals, a fact which only further 
emphasizes the importance of choosing an appropriate mouse model.  Selection of a chemically 
induced mouse model of colon carcinogenesis should be carefully considered.  The cell type of 
interest should respond to the carcinogen of choice without causing death to the rodent.  It is also 
important to recognize the susceptibility to the carcinogen when determining a dosage.  When 
using AOM to induce and mimic a sporadic colorectal carcinogenesis, three mouse strains are 
commonly used: A/J, SWR/J, and AKR/J.  Each of these strains vary in the susceptibility to 
AOM with A/J being most susceptible with largest number of tumors formed and AKR/J  mice 
showing the fewest tumors develop (Nambiar, et al., 2003; Bissahoyo, et al., 2005).  The A/J 
mouse also had a dose-dependent response to AOM and was also able to tolerate higher doses of 
AOM than the SWR/J line (Papanikolaou, et al., 1998; Bissahoyo, et al., 2005). The A/J strain 
was unique among these three strains for the high incidence and range of dysplastic lesions, 
which serves as a putative surrogate endpoint of CRC, induced by AOM-treatment.  
 
Overall Summary 
 Colorectal cancer is an important cause of mortality in the developed world and occurs as 
a consequence of mutational loss of regulation of colonic epithelial cell proliferation; with each 
mutation further stimulating CRC progression.  Preventing this loss of regulation may be 
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possible by manipulating the microbiota, since some metabolic products of microbial 
fermentation, such as butyrate, are known to regulate epithelial cell proliferation and 
differentiation through interaction with the Wnt signaling pathway, an important regulator of the 
colonic epithelium.  Delivery of increased fermentation substrates to the colonic microbiota 
results in increased production of these beneficial substances.  Resistant starch is a source of 
carbohydrate that can be effectively delivered to the colon and used by microbial populations for 
fermentation, with various resistant starches being differentially fermentable.  In this project, I 
therefore hypothesized that resistant starch and the microbial metabolic products generated from 
resistant starch have the potential to regulate the Wnt signaling pathway, controlling proliferation 
of normal and pre-neoplastic (initiated) colonic epithelial cells.  To test this hypothesis, I 
evaluated the effects of several different forms of dietary resistant starch on mRNA levels for 
genes and downstream targets of the Wnt pathway, an important regulator of epithelial cells 
proliferation.   
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ABSTRACT 
 Dietary resistant starches (RS) have positive impacts on colon health and have been 
suggested to reduce colon cancer through production of short chain fatty acids (SCFA) by 
microbial fermentation.  These SCFAs, especially butyrate, are believed to help maintain the 
health of colonic epithelial cells through unidentified interactions with the apoptotic and Wnt 
signaling pathways.  The Wnt pathway regulates cellular proliferation and differentiation.  
Aberrant Wnt signaling is common in colorectal cancer, with mis-regulation and over-expression 
of β-catenin, an intracellular signal transducer of the Wnt signaling pathway, in colonocytes. 
Given that SCFAs have shown potential benefits on colonic signaling mechanisms, we 
hypothesized that diets rich in resistant starch will modulate the activity of the Wnt pathway in 
colonic epithelial cells.  We evaluated intestinal mRNA levels of β-catenin and other genes in 
this pathway among F344 rats fed diets containing 34.5±2.0%, 0.2±0.1%, and 1.9±0.1% resistant 
starch from corn lines Guat209 (GUAT), AR16035 (AR), or a hybrid (ARxGUAT), respectively, 
for 8 weeks following initiation of carcinogenesis by azoxymethane (AOM) treatment. Dietary 
and treatment controls included a diet containing the highly digestible starch, AR, and saline 
injection, respectively.  The incidence of the putative preneoplastic lesions, aberrant crypt foci 
(ACF), was quantified.  Quantitative PCR for genes and targets of the Wnt pathway was 
performed on full-thickness samples of colon wall and on populations of microdissected 
epithelial cells of the mucosal surface and crypt base. In physiologically normal (non-AOM-
injected control) rats fed GUAT, mRNA for β-catenin in samples from full-thickness colon was 
lower, compared with samples from rats fed either AR or ARxGUAT.  Deep crypt colonocytes 
in AOM-injected rats fed GUAT displayed a marked and statistically significant decrease in β-
catenin mRNA expression, compared with a similar population from the saline-injected rats fed 
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GUAT, a change not reflected in similarly treated rats fed control diet.  These results 
demonstrate the potential for resistant starch to modulate the Wnt signaling pathway under 
normal and pre-neoplastic conditions. 
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INTRODUCTION 
 Colorectal Cancer (CRC)  is the third most commonly diagnosed cancer in both men and 
women, with approximately 102,480 new cases of colon cancer in the USA in 2013 alone 
(American Cancer Society, 2013).  While the number of people dying from colorectal cancer has 
slowly begun to decline, probably due to increased screening, current screening methods are 
inexact and can be expensive and uncomfortable.  The use of dietary measures to prevent 
carcinogenesis and tumor progression holds the possibility of dramatically reducing the 
incidence of this disease (Clausen, et al., 1991; Lattimer and Haub, 2010).   
 Dietary resistant starch (RS) shows promise as a prebiotic agent for preventing colorectal 
cancer by modifying cell proliferation and maturation in colonic crypts, the site of intestinal 
mucosal renewal and, in the cancer stem cell model, the location of the cell of origin for 
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colorectal cancer (Vaiopoulos, et al., 2012).  Resistant starches are starch molecules or 
components of starch molecules that are not digested in the small intestine and instead are 
available for fermentation in the colon (Englyst, 1986).  Fermentation by colonic microbes 
produces short chain fatty acids, including butyrate, which are hypothesized to affect the 
development of colon cancer by regulating cell proliferation, differentiation, and migration 
(Fung, et al., 2012). 
 Two naturally occurring maize (Zea mays) lines were used in this study, AR and GUAT.  
Hybridization of AR and GUAT lines were conducted, resulting in a hybrid, ARxGUAT.  Two 
different genetic mutations in corn have been shown to result in higher resistant content, starch 
branching enzyme (sbe1) and amylose extender 1 (ae1).  Corn starch from a starch branching 
enzyme (sbe1) mutant was reported to have an altered molecular structure that  resulted in 
increased resistance to pancreatic α-amylase, β-amylase, and isoamylase, as compared with 
starch lacking this mutation (Xia, et al., 2011).  Amylose extender 1 (ae1) mutants have been 
shown to have longer internal chain lengths in amylopectin and fewer branched outer chains than 
a wild-type starch (Liu, et al., 2009).  The GUAT line contains mutations in both the sbe1 and 
ae1 genes. 
 Butyrate and other products of colonic RS fermentation, through molecular mechanisms 
not fully understood, are believed to regulate the Wnt signaling pathway in colonic epithelium.  
This pathway is a critical regulator of normal colonic epithelial maturation, differentiation, and 
migration, and dysregulation of this pathway is implicated in the development of colorectal 
cancer (Fung, et al., 2012).  The Wnt signaling pathway is active in stem cells and progenitor 
cells that reside deep within the colonic crypts (Reya and Clevers, 2005).  In a cancerous state, 
the Wnt signaling pathway is activated, with the cascade initiated when one of the 16 recognized 
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Wnt glycoproteins binds to Frizzled (Fz) or one of the Secreted Frizzled Related Proteins (SFRP) 
(Polakis, 2000; Huelsken, 2002).  Ligation by either Fz or SFRP causes Axin, with the help of 
APC, to bind to and phosphylorate Dishevelled (DSH).  APC and Axin bind to GSK3-β, which, 
in an unbound state is able to bind to β-catenin and mark it for degradation.  This binding of 
GSK3-β by Axin thus allows β-catenin to accumulate in the cytoplasm and translocate to the 
nucleus (Polakis, 2000; Huelsken, 2002).  Once in the nucleus, β-catenin binds to the LEF/TCF 
complex and transcribes many target genes (Cadigan and Nusse, 1997; Cadigan and Liu, 2005).  
These targets include Axin2, WISP1, and TFRC, which function in assisting to stabilize β-
catenin, stimulate cell growth, and in the uptake of cellular iron, respectively.  Each of these 
target genes is required for cell proliferation and differentiation and their expression will further 
enhance the rate of proliferation of cells (Leung, et al., 2002; Rohrs, et al., 2009).  This becomes 
a positive feedback loop, with the help of other transcription factors, such as HNF1α, allowing 
cells to accumulate β-catenin in the cytoplasm. 
 In the non-canonical pathway, Wnt proteins do not bind to the Frizzled receptors.  This 
lack of binding allows Axin and APC to bind to β-catenin and recruit GSK3-β to phosphylorate 
β-catenin (Holcombe, et al., 2002; Reya and Clevers, 2005).  Because of this phosphyloration, β-
catenin is degraded and cytoplasmic accumulation is prevented.  Subsequently, Wnt target genes 
are not transcribed and cells are not stimulated to divide, due to lack of a positive growth signal 
(Dienz and Clevers, 2000; de Sousa, et al., 2011).   
 As the cells migrate up the crypt, there is a progressively diminished effect of Wnt 
signaling (Nusse, 2008).  Since the Wnt pathway is most active in the deep regions of the crypt, 
the location of the stem cell niche, we hypothesized that dietary resistant starch will inhibit the 
Wnt signaling pathway of epithelial cells in this important intestinal microenvironment.  We also 
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hypothesize that diets containing the highly resistant starch GUAT will reduce the development 
of a putative pre-neoplastic lesion, aberrant crypt foci (ACF), in the colonic epithelium of 
carcinogen-induced rats.   
 
 
MATERIALS AND METHODS 
 
Maize Hybrids and Starch Preparation. Starch isolated from kernels of two genotypes of 
maize and a hybrid of those two genotypes was used in this study.  One genotype, GUAT209 
(also known as GEMS-0067 and labeled GUAT in this study), is derived from a combination of 
tropical and temperate germplasm and is homozygous for the amylose extender 1 (ae1) mutation, 
which is known to increase levels of resistant starch in the kernel (Campbell et al., 2007).  
GUAT is a low-yielding Guatemalan landrace line with amylose content up to 70%.  In addition 
to ae1, this line contains additional high amylose modifier genes, like sbe1, that further increase 
the level of resistant starch (Wu et al., 2009).  The GUAT line is classified as a resistant starch 
type 2 (RS type 2).  The second genotype tested in the study (labeled ARxGUAT) is a hybrid 
between GUAT and a high-yielding and highly digestible, experimental, exotic Argentinian 
variety (AR1035 and designated AR in this study) (Table 1).   Kernels of the three varieties were 
produced under similar field conditions, harvested at maturity, dried to approximately 12% 
moisture, and shelled prior to being used to make the starch for inclusion in dietary treatments 
described in this study. 
 
Starch Processing.   Kernels from the three lines were steeped in a 50-L 0.2% SO2, 
0.5% Lactic Acid Solution.  The kernels were then ground coarsely and the germ separated with 
a sieve from the fiber slurry, which was further ground finely to allow for separation into 
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fractions.  The fine fiber was separated through a series of washing steps using water, leaving the 
gluten and starch.  The gluten-starch mixture was allowed to settle at a specific gravity of 1.04, 
resulting in two distinct layers.  The starch was then separated from the gluten by the process of 
tabling (1.5-L/min, 0.6° slope), dried, and ground into a fine powder for use in the study. 
 
Diets.  Starches from the three maize varieties were cooked by a water-boiling method and then 
mixed with the remaining components of the diet (Zhao, et al., in press 2014).  The diet 
formulation was based on the American Society for Nutritional Sciences' standard diet 
recommendations for mature rats (AIN-93M) (Reeves, 1997).  However, the 5% cellulose in the 
AIN-93M was not included and the starch content was increased by this amount, resulting in a 
55% starch content (Table 2).  The boiling procedure was formulated by Zhao, et al. with fresh 
diet cooked every other day (Zhao, et al., in press 2014).  The resistant starch content of the 
starches and of freshly made diets were measured by the AOAC method 991.43 (Horwitz, 2003).  
The water content of these samples was determined by a Sartorius moisture analyzer MA30 
(Bohemia, NY).  Levels of resistant starch and water content were measured in three randomly 
selected samples of each starch or diet (Table 3). 
 
 Animals and Housing. Five-week-old, male, Fischer 344 (F344) rats (Charles River 
Laboratory, Wilmington, MA) were used for this study.  The rats were housed individually in 
plastic cages with stainless-steel, wire-mesh tops.  The rats were divided randomly into three 
equal diet groups (AR, ARxGUAT, and GUAT) with 15 rats in each group.  Once rats were 
divided into the three feeding groups, stainless-steel wire floors were placed in the cages to 
prevent coprophagia.  The rooms were maintained at 22±1ºC with 60±5% humidity and the room 
42 
 
 
 
had a 12-hour light-dark cycle.  Diet and water were provided ad libitum.  The animal studies 
were approved and performed in compliance with the Institutional Animal Care and Use 
Committee of Iowa State University.   
 
Carcinogen Treatment.  Azoxymethane (AOM, Midwest Research Institute, Kansas City, MO), 
a widely accepted colon carcinogen (Bissahoyo, et al., 2005), was injected intraperitoneally 
(20mg AOM/kg body weight) into 10 rats from each diet group once a week for two weeks.  As 
a negative control, the remaining 5 rats from each diet group received intraperitoneal injections 
of an equivalent volume of sterile physiological saline at the same time as the administration of 
AOM. 
 
Diet Treatment.  All rats were fed the AR diet from arrival until three days after the last AOM 
injection.  The rats in each treatment group were then fed the test or control diets for 10 weeks.  
Body weights were measured weekly and food disappearance was measured by calculating the 
difference between the amount of food presented to the animals and the amount remaining 
uneaten at the end of each feeding.  At the end of the 10-week period, rats were humanely 
euthanized individually by CO2, necropsied immediately, and samples were collected for further 
analysis. 
 
Necropsy and tissue sampling. At necropsy, the liver and cecum, with contents, of each rat was 
removed and weighed.  The colon of each rat was removed, incised longitudinally, and flushed 
with phosphate buffered saline.  Each colon was laid flat and the distal 50 mm segment was cut 
and fixed flat between two glass slides in 10% formalin for at least 24 hours before staining for 
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Aberrant Crypt Foci.  A 1-cm section of the subterminal region of the colon, 6.5 cm anterior to 
the anus, was removed and frozen in RNA Later (Life Technologies, Grand Island, NY) until 
RNA extraction of the full-thickness colon was performed. Additionally, a 3-mm section of the 
colon, immediately adjacent to the sample used for colonic whole tissue analysis was excised 
and snap-frozen in O.C.T (Optimal Cutting Temperature) compound, (VWR, Radnor, PA) and 
stored at -80OC until tissue sections were collected for microdissection. 
 
Cecal Weight and pH.  The cecum, after removal, was weighed, and then incised and contents 
were gently removed and the pH of the contents was measured.  The cecal wall was then rinsed 
in phosphate buffered saline, gently blotted dry with an absorbent paper towel and weighed to 
record the cecal tissue weight.  The cecal content weight was calculated as the difference of the 
cecal weight and cecal tissue weight.   
 
Aberrant Crypt Foci.  The formalin-fixed distal 50 mm section of each colon was stained with 
1% alcian blue in acetic acid (pH 2.5), counterstained with 1% neutral red, rinsed, gently blotted 
dry, placed on a glass microscope slide, and ACF were counted using a light microscope (Bird, 
1998).   
 
RNA collection and processing from full-thickness and microdissected colon.  Relative 
mRNA levels for 9 genes were determined from full-thickness tissue samples of the colon, 
consisting of mucosa, submucosa, muscular, and serosal layers.  RNA isolation was performed 
using Trizol (Invitrogen, Carlsbad, CA), further purified with RNeasy Kit (QIAGEN, Valencia, 
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CA) and the quantity and quality of the isolated RNA was determined using a Nanodrop 1000 
Spectrophotometer (Thermo Scientific, Wilmington, DE).  
 For microdissected populations of cells, blocks of tissue containing the 3mm section of 
colon were equilibrated to -20OC and tissues sectioned to 10 microns, using a cryostat with 
chuck and cabin maintained at -20OC, and collected onto SuperfrostPlus microscope slides and 
placed at -80OC until staining and laser microdissection was performed the next day.   Sections 
were stained using the Arcturus HistoGene LCM frozen section staining kit (Life Technologies, 
Grand Island, NY) and stored in xylene for laser microdissection.  Epithelial cell populations 
from the luminal surface and deep within the crypts, (up to the +3 cells, representing the stem- 
and progenitor-cell populations), were captured independently with a PixCell II Laser Capture 
Microdissection System (Life Technologies, Grand Island, NY).  Approximately 500 cells were 
collected for each sample location.  Extraction of RNA from each sample was performed 
according to the PicoPure RNA Isolation protocol (Life Technologies, Grand Island, NY) and 
residual DNA was removed (DNA nuclease kit, QIAGEN, Valencia, CA).  The quantity and 
quality of the isolated RNA was confirmed with Nanodrop 1000 Spectrophotometer (Thermo 
Scientific, Wilmington, DE) with an average of 8ng/ul and 260/280 ratio of 1.74±0.4.  The 
quality of RNA obtained from the microdissected cells was lower than is usually acceptable for 
qPRC (1.80), but the amount of RNA obtained from microdissected cells is small, which could 
contribute to this measurement, and the differences from the accepted quality standard were 
relatively small. 
 
Semi-qualitative, real-time PCR.  DNA-free RNA collected from the colonic tissue specimen 
was reverse transcribed using iScript cDNA synthesis kit (BioRad, Hercules, CA).  Eight genes 
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encoding members of the Wnt pathway or a downstream target (APC, β-Catenin, TFRC, Wnt 8a, 
HNF1A, Axin 2, WISP, and SFRP4 (Table 4) were selected for quantitative real-time PCR 
analysis (qRT-PCR) to identify effects on regulation of the Wnt signaling pathway among the 
different treatments (saline vs. AOM) and diets (AR, ARxGUAT, and GUAT).  GAPDH was 
used as a reference gene as our pilot studies demonstrated relatively uniform expression of this 
gene as compared with PSMB6 and PMM1(data not shown), which was in accordance with 
previous reports (Rubie, et al., 2005).  The primers used for qPCR were designed using the 
software PrimerQuest (Integrated DNA Technologies, Inc., Coralville, IA) and synthesized by 
Integrated DNA Technologies, Inc. (Table 4).  SYBR Green Supermix kit (BioRad, Hercules, 
CA) was used for the qPCR procedure according to the manufacturer's instructions.  A Roche 
Light Cycler 96 PCR instrument was used with conditions of 95 °C for 3 min, and 40 cycles of 
95 °C for 15 s, annealing temperature of the primer for 30 s, and 72 °C for 30 s, followed by 95 
°C for 1 min, and 55 °C for 1 min.   
 DNA-free RNA samples isolated from cells microdissected from the deep regions of the 
colonic crypts or the luminal epithelial surface of each rat were reverse transcribed using iScript 
cDNA synthesis kit (BioRad, Hercules, CA).  Two genes involved in Wnt signaling, β-Catenin 
and TFRC, were selected for quantitative real-time PCR analysis (qPCR) with GAPDH used as a 
reference gene (Table 4).  The qPCR procedure was performed using the SYBR Green Supermix 
kit (BioRad, Hercules, CA) according to the manufacturer's instructions.  A GeneAmp 5700 
Sequence Detection System was used with conditions of 95 °C for 3 min, and 45 cycles of 95 °C 
for 15 s, annealing temperature of the primer for 30 s, and 72 °C for 30 s, followed by 95 °C for 
1 min, and 55 °C for 1 min.   
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Statistical Analysis.  Body weight, food disappearance, liver weight, cecal weights and pH, 
numbers of ACFs, and average crypts/focus, were analyzed using One-way ANOVA or 
Kruskal-Wallis tests, depending on normality of the data set.  Two-sided t-tests were also 
applied to test the significant differences between groups. ∆Cq values from PCR data from each 
experiment were calculated (Bustin, et al., 2009).   ∆∆Cq values used to calculate fold-change 
as described by Pfaffl et al. (Tables 5 and 6).  Differences in ∆Cq values were analyzed using 
ANOVA with post-test (Two-way analysis of variance and Tukey’s multiple comparison test for 
normally distributed data or Kruskal-Wallis test and Dunn’s multiple comparison test for data 
that was not normally distributed) (Tables 7 and 8) and Student's t-tests.   All values were 
reported as mean + standard deviation, with the exception of fold-change data. A p-value < 0.1 
was considered significant for qPCR data while a p-value <0.5 was used for all other data.  Data 
analysis was performed using SAS and/or GraphPad Prism. 
 
RESULTS 
Resistant starch content isolated from corn lines and in experimental diets.  The degree of 
dietary resistance of starch derived from each of the three corn lines, AR, ARxGUAT, and 
GUAT, are 0.2 + 0.1%, 1.9 + 0.1%, and 34.5 + 2.0%, respectively.  Resistant starch content of 
the AR, ARxGUAT, and GUAT diets as fed were 5.4 + 0.5%, 8.6 + 0.6% and 18.6 + 0.9%, 
respectively, based on dry weight, and the water content of the diets was 20.0 + 0.9%, 13.0 + 
1.0%, and 14.1 + 0.9%, respectively (Table 3).  
 
Body weight, food disappearance, and liver weight.  Significant differences were not observed 
in the body weight gain or food disappearance among groups over the 8-week experimental 
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period.  An average of 175 + 6 g body weight was gained, while there was an average daily food 
disappearance of 15.2 + 1.4 g/day.  AOM or diet effects were not observed on the liver weight 
data. 
 
Cecal pH and weights.  The pH of the cecal contents of GUAT-fed rats was significantly 
decreased when compared with cecal pH of rats fed diets containing either AR or ARxGUAT, 
regardless of the absence or presence of AOM treatment (p<0.0001) (Figure 1A). 
Rats fed a diet containing the GUAT starch had significantly elevated cecal tissue weight, 
when compared with cecal weights of rats in either the AOM- or saline treated groups fed AR or 
ARxGUAT diets (p<0.0001) (Figure 1C).  Cecal content weight was also significantly elevated 
in rats fed the GUAT diet compared with rats fed AR or ARxGUAT diets in AOM-treated and 
saline-treated groups (p<0.0002) (Figure 1B).  
  
Aberrant Crypt Foci.  Aberrant crypt foci (ACF) were only observed in the colonic mucosae of 
AOM-treated rats (p<0.0001) (Figure 2A).  AOM-treated, GUAT-fed rats had a 37% decrease in 
ACF number when compared with the AOM-treated, AR-fed rats, but this difference was not 
statistically significant (p=0.2961).  A 26% decrease in ACF number was also present in the 
ARxGUAT-fed rats compared with the AR-fed rats, also not statistically significant (p=0.4243). 
The colons of GUAT-fed rats had a statistically significant increase in the average number of 
crypts/aberrant crypt focus when compared with colons of rats fed the AR diet (p=0.0304) 
(Figure 2B).   
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Expression of Wnt pathway-related genes in whole tissue specimens of colon.  This first 
experiment used the full-thickness sample of colon, deriving the mRNA from cell populations 
comprising all of the layers of the colonic wall, mucosa, submucosa, muscular tunics, and serosa.  
β-catenin mRNA expression was significantly decreased in colonic walls of ARxGUAT-fed rats 
injected with AOM compared with the ARxGUAT-fed rats injected with saline (p=0.02).  β-
catenin mRNA expression was also decreased significantly, compared with the AR-fed rats 
injected with AOM (p=0.05) (Figure 3A).  TFRC mRNA levels were decreased in the AR-fed 
rats injected with AOM compared with the AR-fed rats injected with saline (Figure 3B).  In rats 
with saline treatment, the mRNA levels for TFRC were lower in ARxGUAT-fed rats compared 
with AR-fed rats (p=0.04) (Figure 3B).  Axin2 mRNA expression displayed a decreased 
expression in both the saline and AOM treatment groups of GUAT-fed rats compared with the 
respective treatment groups fed the AR-diet (p=0.09 and p=0.04, respectively).  Axin2 mRNA 
expression was also decreased in the AOM-injected rats fed the GUAT diet relative to the AOM-
injected rats fed the ARxGUAT diet (p=0.01) (Figure 3C).  HNFIα mRNA expression was 
decreased in the AOM-injected rats fed the ARxGUAT diet, compared with both the 
ARxGUAT-fed rats injected with saline and the AR-fed rats injected with AOM (p=0.08 and 
p=0.06) (Figure 3D).  The mRNA level of SFRP4 was significantly increased in the GUAT diet 
group compared with both the AR and ARxGUAT diet groups in AOM-injected rats (p=0.005 
and p=0.002, respectively).  SFRP4 mRNA expression was also decreased in saline-injected rats 
fed either the ARxGUAT or GUAT diets, compared with the AR-fed rats (p=0.06 and p=0.008, 
respectively) (Figure 3E).  WISP1 mRNA expression in saline-treated rats was lower in 
ARxGUAT- and GUAT-fed rats compared with AR-fed rats (p=0.04 and p=0.1).  Among the 
AOM-injected rats, rats fed the ARxGUAT diet had decreased mRNA expression of WISP1 
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compared with rats fed either the AR or GUAT diets (p=0.03 and p=0.06) (Figure 3F). There 
were no significant differences in ∆Cq results for mRNA encoding APC or Wnt8a when 
comparing AOM-injected rats with saline-injected rats or when comparing data from non-
initiated rat colons between diet groups (Figure 3G and H).   
 
Expression of Wnt pathway genes by surface and crypt colonocytes.  To investigate the 
effects of dietary RS on mRNA encoding β -catenin or TFRC at the anatomic location of 
epithelial proliferation and, cells residing in two microenvironmental niches of the epithelium, 
namely the deep regions of crypts and the luminal surface, sites of stem/progenitor and 
differentiated cell populations, respectively, were isolated by microdissection and gene 
expression was evaluated by qRT-PCR. In saline-treated mice fed the GUAT diet, β-catenin 
mRNA expression was increased compared with the saline-treated mice fed the ARxGUAT diet 
(p=0.003) (Figure 4B).  β-catenin mRNA levels were decreased in deep crypt colonocytes of 
AOM-injected rats fed the GUAT diet, relative to the saline-injected (control) rats fed the GUAT 
diet (p=0.03).  This significant decrease in β-catenin mRNA level was only present in GUAT-fed 
rats, and not in either AR- or ARGUAT-fed, AOM-injected rats (Figure 4A and B). β-catenin 
mRNA expression by surface colonocytes, but not deep crypt cells, was lower in the AOM-
injected, ARxGUAT-fed mice relative to the AOM-injected, AR-fed mice (p=0.007).  β-catenin 
mRNA expression, of both the surface and crypt, were both similarly decreased in GUAT-fed 
rats and not in AR-fed, AOM-injected rats (p=0.09 and p=0.07, respectively).  Significant 
differences were not present in ∆Cq data for TFRC expression (Figure 4C and D).        
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DISCUSSION 
 The inclusion of highly resistant starch, GUAT, in the diet of rats in the preneoplastic 
stage of colon cancer resulted in a significant decrease in β-catenin mRNA levels in the colonic 
epithelium.  A large body of evidence demonstrates that decreased β-catenin mRNA levels are 
indicative of a non-active Wnt signaling pathway (Polakis, 1999; Polakis, 2000; Hirose, et al., 
2003; Feng Han, et al., 2006; Segditsas and Tomlinson, 2006). This model correlates to our 
mRNA expression data of other key genes in the Wnt signaling pathway, which also point toward 
a potentially inactive state of the Wnt signaling pathway in GUAT-fed rats injected with AOM. 
 Analyses of the starches and diets demonstrate a statistically higher percentage of 
digestion resistance in starch from the GUAT maize line, compared with starch digestion 
resistance from the AR or ARxGUAT lines (p<0.05).  The rats fed the GUAT diet had 
significantly increased cecal tissue and content weight compared with rats fed either the AR or 
ARxGUAT diet, suggesting lower digestibility in the small intestine, with a higher volume of 
residual starch in the ingesta entering the cecum and colon.  The GUAT-fed rats may therefore 
be experiencing increased colonic fermentation, which we hypothesize to be due to increased 
amounts of starch available for the colonic microbiota.  These increases in weight are 
hypothesized to be primarily due to an increase in the mass of the food product and a 
corresponding hypothesized increase in bacterial mass (Konishi, et al., 1984; Wollowski, et al., 
2001).   
 Decreased cecal pH was only present in rats fed the diet containing the highest 
concentration of resistant starch, GUAT, compared with rats fed AR or ARxGUAT diets, which 
have a normal pH, regardless of AOM or saline injection status.  Microbial fermentation of 
resistant starch in the rat colon has been shown to not only increase cecal weight, but also 
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decrease cecal pH (Konishi, et al., 1984).  We hypothesize that the lowered pH of the cecal 
contents reflects increased microbial production of acidic metabolic products, including short 
chain fatty acids such as butyrate.  Future studies are needed to better characterize the microbial 
responses to dietary resistant starch.  
 Altered crypt foci, putative preneoplastic lesions, were only observed in rats that had 
received AOM treatment, which supports the well-established concept of azoxymethane being 
able to initiate carcinogenesis in the colon (Bissahoyo, et al., 2005).  The highest number of ACF 
were measured in the rats fed the diet with highly digestible starch, while the rats fed high levels 
of resistant starch had the lowest average number ACF; though this difference was not 
statistically significant (p=0.29).  However, GUAT-fed rats injected with AOM had a statistically 
higher number of ACF multiplicity compared with both the AR- and ARxGUAT-fed mice 
(p<0.05), indicating the possibility of an interaction between the GUAT diet and AOM treatment 
that affects differentiation of crypt colonocytes.  This increased multiplicity of ACF has been 
related to a later stage of progression, although recent research suggests that ACF, in general, 
may not be a highly predictive biomarker for future colon carcinogenesis (McLellan, et al., 1991; 
Hirose, et al., 2003). 
 The use of azoxymethane (AOM) has been shown to initiate the Wnt signaling pathway 
and cause an increase in cell proliferation (Takahashi and Wakabayashi, 2004). In our study, we 
observed changes in gene expression in AOM-treated rats that were consistent with a mixed 
pattern of up- and down-regulation of the Wnt pathway. Full-thickness colon samples from rats 
fed the control diet demonstrate increased Axin2 mRNA in the AOM-initiated mice relative to 
the saline-injected mice (p=0.12).  However, TFRC, SFRP4, and WISP-1 mRNA expression in 
the full-thickness samples are decreased in AOM-initiated mice relative to the saline-injected 
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mice fed the control AR diet (p=0.1, p=0.005, and p=0.0003, respectively).  An alternate 
pathway, such as the apoptotic or Notch pathway, may be affecting the mRNA expression of 
these three genes and potentially other untested genes of the Wnt signaling pathway in the AOM-
initiated full-thickness samples of the control fed rats as TFRC, SFRP4, and WISP-1 have been 
shown to be up-regulated by AOM induction (Chen and Huang, 2009; Davies, et al., 2010; 
Vaiopoulos, et al., 2012).   
 Diets containing moderate or high levels of resistant starch also modify mRNA 
expression of genes of the Wnt signaling pathway. ARxGUAT diet fed to saline-injected mice 
decreased TFRC, SFRP4, and WISP-1 mRNA levels relative to the control AR fed mice injected 
with saline (p=0.04, p=0.06, and p=0.04, respectively).  Although these three genes play roles in 
multiple pathways (Rohrs, et al., 2009; Davies, et al., 2010), the ability of the ARxGUAT diet to 
decrease mRNA expression is still important.  ARxGUAT fed in the diet not only reduces 
mRNA expression in saline-injected mice, but also in those injected with AOM. β-catenin, 
HNF1α, SFRP4, and WISP1 mRNA levels are all decreased in the full-thickness colonic tissue in 
AOM-injected rats fed the ARxGUAT diet, relative to the control, AR-fed mice injected with 
AOM (p=0.05, p=0.06, p=0.08, and p=0.03, respectively), suggesting that ARxGUAT fed in the 
diet may be able to down-regulate the Wnt signaling pathway in an initiated-state.  This study 
only looked at the preneoplastic stage of colon cancer, but the ability of a moderately resistant 
starch, ARxGUAT, in the diet to decrease mRNA expression levels at this stage demonstrate that 
resistant starch has strong potential for inhibiting cell proliferation. 
 A highly resistant starch, GUAT, in the diet has also demonstrated an ability to 
effectively decrease mRNA expression in the full-thickness colon samples and in site specific, 
(surface or crypt) epithelial cell populations of the colon.  Mice fed the GUAT diet and injected 
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with saline have decreased TFRC, Axin2, SFRP4, and WISP-1 full-thickness mRNA levels 
relative to the control, AR- fed mice injected with saline (p=0.10, p=0.09, p=0.008, and p=0.10, 
respectively).  These mRNA expression levels demonstrate that both low and high levels of 
resistant starch content in the diet are able to down-regulate the Wnt signaling pathway.  GUAT 
in the diet is able to decrease mRNA expression of Axin2 in the full-thickness colon, which was 
not down-regulated by the ARxGUAT diet.  The decrease of another gene is hypothesized to be 
due to the increased resistant starch content of GUAT and suggests that a higher level of resistant 
starch has a greater impact on maintaining the colon in a normal, non-initiated, state.  GUAT fed 
in the diet does not only reduce mRNA expression of the full-thickness colon in saline-injected 
mice, but also in those injected with AOM. The Axin2 mRNA level of the full-thickness colon is 
decreased in AOM-injected rats fed the GUAT diet relative to the control, AR, fed rats injected 
with AOM (p=0.04).  The decrease in Axin2 mRNA expression suggests an ability of this dietary 
resistant starch, GUAT, to not only influence expression in a saline-injected model, but also in an 
AOM-injected model.  GUAT fed in the diet of rats injected with AOM also had a decreased β-
catenin mRNA expression both the colonic epithelial surface and epithelial crypt relative to 
AOM-injected rats fed the AR, control, diet (p=0.007 and p=0.07).  β-catenin mRNA levels are 
also decreased in the AOM-injected rats fed the GUAT diet relative to the saline-injected rats fed 
the GUAT diet (p=0.03).  Decreased β-catenin levels have been shown to be indicative of a non-
active Wnt signaling pathway.  This decrease in β-catenin mRNA levels of the full-thickness 
tissue and of the niche specific cells correlates to our mRNA expression data of other key genes 
in the Wnt signaling pathway, which also point toward a potentially inactive state of the Wnt 
signaling pathway in GUAT-fed rats injected with AOM.   
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 Overall, these results demonstrate that increased levels of dietary resistant starch were 
able to modify the expression of genes encoding β-catenin, TFRC, Axin2, SFRP4, and WISP-1 of 
the Wnt signaling pathway in both the full-thickness colon and in the stem cell niche and mature 
surface colonocytes of rats injected with AOM and fed the ARxGUAT or GUAT diet.  The 
GUAT diet was able to decrease the mRNA expression of a few more genes than that of the 
ARxGUAT diet in AOM-injected rats suggesting that the level of resistant content is important 
and that a higher resistant content may be able to decrease overall Wnt signaling to a greater 
degree.   
 With the exception of the increased ACF multiplicity, mRNA data suggest an ability of 
GUAT fed in the diet to inhibit the Wnt signaling pathway.  This suggests an ability of resistant 
starch to decrease the mRNA expression of key genes of the Wnt signaling pathway (Giles, et al., 
2003; Segditsas and Tomlinson, 2006).  Future studies are needed to investigate the effects of 
both AOM and diet on the protein levels of the Wnt signaling pathway. 
 We also demonstrated the important differences in gene expression patterns between 
samples derived from whole tissue and discrete populations of cells residing in different mucosal 
microenvironments.  This highlights the importance of evaluating mRNA levels from specific 
populations of cells.    
  
ABBREVIATIONS 
ACF, Aberrant Crypt Foci 
AOM, Azoxymethane 
AR, AR starch diet 
ARxGUAT, Hybrid resistant starch diet from parental lines, AR and GUAT 
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CRC, Colorectal cancer 
GUAT, Guat starch diet 
LCM, Laser Capture Microdissection 
O.C.T., Optimal Cutting Temperature  
RS, Resistant Starch 
 
SAFETY 
 Azoxymethane is a potent carcinogen used experimentally to induce colon cancer in rats 
and mice. It might cause harm to human if swallowed, inhaled or absorbed through skin. 
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FIGURE LEGENDS 
 
 
Figure 1.  Cecal endpoints from AOM-initiated experimental and saline-injected control 
rats fed diets containing AR, ARxGUAT, or GUAT starches: (A) pH of cecal contents; (B) 
Cecal content weight (g); (C) Weight of cecal wall (g).  Values are means +SD.   Mean values 
are significantly different from those for the both the AR and ARxGUAT Saline group (*bars) or 
both the AR and ARxGUAT AOM group (**bars) with both representing P<0.05.  
Figure 2. Altered crypt foci observed in the distal colon of AOM-initiated rats fed diets 
containing AR, ARxGUAT, or GUAT starches (rats were euthanized 9 weeks after the first 
AOM injection): (A) average ACF number; (B) average crypts/focus in ACF. Values are means 
+SD. *bars are significantly different P-value < 0.05 with n=10 for all AOM-injected groups and 
n=2-3 for saline-injected control groups.  
Figure 3A-H. mRNA expression of Wnt pathway-related genes in the full thickness colon of 
rats fed diets containing AR, ARxGUAT, or GUAT starches.  Data reported are ∆Cq 
values, using the ∆∆Cq method.  Each AOM group had n=10 while each saline group had n=2-
3. Bars represent statistical significance with one star (*) representing= p-value <0.1, two (**) 
represent= p<0.05, and three (***) represent= p<0.001. P-values of the Two-Way ANOVA 
analysis for each mRNA species are listed in Table 7. 
Figure 4A-D. mRNA expression measured as ∆Cq of β-Catenin and TFRC standardized 
using the ∆∆Cq Method for surface and crypt niches. Each AOM group had n=10 while each 
saline group had n=2-3. Bars represent statistical significance with one star (*) representing= p-
value <0.1, two (**) represent= p<0.05, and three (***) represent= p<0.001.  P-values of the 
Two-Way ANOVA analysis for β-Catenin and TFRC mRNA are listed in Table 8. 
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TABLE LEGENDS 
Table 1.  Pedigree Information and Nomenclature for Corn Lines.    
Table 2. Diet Ingredients. Components of the starch diet as characterized by Zhao et al (in press 
2014). 
Table 3. Resistant Starch and Water Content of Starches and Diets.  Percentage resistant 
starch content of the starch and of the diet was determined using the AOAC method 991.43. 
Table 4.  Primer Sequences for qPCR of Rat Colon Samples.   
Table 5. Modulation of mRNA expression of genes of the Wnt pathway by dietary resistant 
starch in full-thickness colon tissue samples of AOM-injected and control rats.  With 
comparisons made within and across diets ∆∆Cq method.  * indicates statistical significance 
(p<0.10). 
Table 6. Modulation of mRNA expression of β-catenin and TFRC in Surface and Crypt 
Niches.  Comparisons made within and across diets using the ∆∆Cq method.  * indicates 
statistical significance (p<0.10). 
Table 7. P-values of Two-Way ANOVA of genes of the Wnt pathway in full-thickness colon 
tissue samples. 
Table 8. P-values of Two-Way ANOVA of mRNA expression of β-catenin and TFRC in 
Surface and Crypt Niches. 
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TABLES 
 
 
 
Table 1.  Pedigree information nomenclature for corn lines. 
 
Abbreviation Field Data of Corn Lines 
AR AR011050:S01:1082)-01-02 
ARxGUAT GUAT209:S13//Oh43ae/H99ae-1-2-1)-B/3 / AR011050:S01:1082)-03)-02-10 
GUAT GUAT209:S13//Oh43ae/H99ae-1-2-1)-B-B-02  (alternate name: GEMS-0067) 
 
 
 
 
 
 
 
 
 
 
Table 2: Diet Ingredients1. 
 
 
 Diet Ingredient   
 Diet 
Components 
 
  
 
    
 starch 55.0% 
 
 casein 20.0% 
 
 Dextrose 15.0% 
 
 cellulose (insoluble fiber) 0.0% 
 
 mineral mix (AIN-93) 3.5% 
 
 choline 0.2% 
 
 methionine 0.3% 
 
 vitamin mix (AIN-93) 1.0% 
 
 corn oil 5.0% 
 
    
 
1.
 Starches were cooked using a water-boiling method as described in the text. All non-
starch diet ingredients were purchased from Harland Teklad (Madison, WI) or 
Spectrum (Gardena, CA). 
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Table 3: Resistant starch and water content of starches and diets. 
 
 
 
 
 
Starch Groups 
Resistant Starch 
Content of the Starches 
on a Dry Diet Basis 
Resistant Starch 
Content of the Diets 
on a Dry Diet Basis 
Water Content of the 
Diets 
 
(n=2) (n=3) (n=3) 
 
(% + sd) (% + sd) (% + sd) 
AR 0.2 ±0.1% 5.41+0.53% 20.01+0.92% 
ARxGUAT 1.9 ±0.1% 8.57+0.59% 12.99+0.98% 
GUAT 34.5 ±2.0% 18.58+0.90% 14.12+0.89% 
Data are expressed as mean + SD. Resistant starch contents of diets 
were measured by AOAC method 991.43. 
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Table 4.  Primer Sequences for qPCR of Rat Colon Samples 
 
Gene Name Primer Sequence 
GAPDH Forward 
Reverse 
ACAGTCGATTACAGACAGGCGCAA 
TTCACTGTGTCACGAGCAGCTT 
APC Forward 
Reverse 
ACCAATATGGGTATCAAGCGCGTC 
CGATGGTGACACAGGCACAAACAT 
Axin 2 Forward 
Reverse 
GAGGATGTCTTCTGTCGGGG 
AGCACTGAGCAACTGAGGTC 
β-catenin  Forward 
Reverse 
AGGAAGTGGCTGTCAAGGAGGAAA 
TGGCTTTACTTCTTCCACGGGTGA 
HNF1A Forward 
Reverse 
TAAGGATCCCACCCTGTCCC 
CCCCAAGTTACCTTTCCCCC 
SFRP4 Forward 
Reverse 
CTGCTTAGAGCCCACCAGTT 
TGAGAGCGTTCTTAGCCACC 
TFRC Forward 
Reverse 
CAAGACAGCTCAAACAGTGCT 
GCTGCACTAAGTGGCATGTG 
WISP-1 Forward 
Reverse 
AGAAGGGGTCAGTGAGGGAA 
AGCCGGCATGTTCTTTCGTA 
Wnt 8a Forward 
Reverse 
ACAGTGAGGCTACAGGGCTATCAT 
TCCTGACAGGGCATACCAATGCTT 
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Table 5. Modulation of mRNA expression of genes of the Wnt pathway by dietary resistant 
starch in full-thickness colon tissue samples of AOM-injected and control rats.  * indicates 
statistical significance (p<0.10). 
 
 
Effect of Dietary Resistant Starch on Gene Expression in Control, Saline-Treated (normal) Colon (b) 
Diets (a) 
 
β-catenin APC TFRC Wnt 8a Axin2 HNF1A SFRP4 WISP 
ARGUAT 0.90 1.05 9.98* 1.28 2.70 0.37 12.01* 8.94* 
GUAT 1.04 1.64 1.88* 0.61 12.97* 0.49 6.42* 9.14* 
a= animals not treated with AOM; ΔΔCq calculated comparing test diets to control (AR) diet 
b= fold change 
       
       Effect of Dietary Resistant Starch on Gene Expression in AOM-Induced Colon (b) 
 Diets (c)  β-catenin APC TFRC Wnt 8a Axin2 HNF1A SFRP4 WISP 
ARGUAT  2.82* 3.30 1.46 1.88 0.62 5.06* 3.37* 3.17* 
GUAT  2.76 1.80 1.36 3.79 11.29* 1.79 0.03* 0.51 
b= fold change 
c= animals treated with AOM; ΔΔCq calculated comparing test diets to control (AR) diet 
 
 
Effect of AOM-Induction on Gene Expression in the Colon (b) 
 Treatments (d) β-catenin APC TFRC Wnt 8a Axin2 HNF1A SFRP4 WISP 
AR 1.06 1.26 4.57* 0.64 4.66 0.33 12.43* 8.34* 
ARGUAT 3.31* 3.96 0.67 0.93 1.07 4.54* 3.49 2.95 
GUAT 2.80 1.38 3.31 3.92 4.05 1.21 0.06* 0.46 
b= fold change 
d= ΔΔCqs calculated comparing AOM-treatment with saline-treatment for each diet 
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Table 6. Modulation of mRNA expression of β-catenin and TFRC in Surface and Crypt 
Niches.  * indicates statistical significance (p<0.10). 
 
 
Effect of Dietary Resistant Starch on gene expression in saline-treated (normal) 
colon (b) 
Diets (a) 
Beta-catenin 
Surface 
Beta-catenin 
Crypt 
TFRC 
Surface 
TFRC Crypt 
ARxGUAT 3.91 8.16* 0.93 0.40 
GUAT 0.78 0.28 0.43 0.10 
a= animals not treated with AOM; ΔΔCq calculated comparing test diets to control (AR) diet 
b= fold change 
    
     
Effect of Dietary Resistant Starch on Gene Expression in AOM-Induced colon (b) 
Diets (c) 
Beta-catenin 
Surface 
Beta-catenin 
Crypt 
TFRC 
Surface 
TFRC Crypt 
ARxGUAT 19.27* 2.15 0.96 0.16 
GUAT 7.12* 7.65* 1.11 0.28 
     b= fold change  
c= animals treated with AOM; ΔΔCq calculated comparing test diets to control (AR) diet 
    
     Effect of diet and AOM-Induction on Gene Expression in the Colon (b) 
Treatments (d) 
Beta-catenin 
Surface 
Beta-catenin 
Crypt 
TFRC 
Surface 
TFRC Crypt 
AR 0.55 3.23 0.45 2.84 
ARxGUAT 2.71 0.85 0.47 1.13 
GUAT 5.03 88.53* 1.18 7.58 
 
b=fold change  
d= ΔΔCqs calculated comparing AOM-treatment with saline-treatment for each diet 
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Table 7. P-values of Two-Way ANOVA of genes of the Wnt pathway in full-
thickness colon tissue samples. 
 β-catenin APC TFRC Wnt 8a Axin 2 HNF1α SFRP4 WISP-1 
Interaction 0.58 0.76 0.57 0.57 0.56 0.09 0.002 0.09 
Diet (a) 0.62 0.77 0.40 0.86 0.007 0.67 0.001 0.04 
Treatment (b) 0.10 0.39 0.36 0.70 0.13 0.78 0.58 0.12 
a=p-values of the effect of the diet with p<0.1 being significant 
b=p-values of the effect of either saline or AOM injection with p<0.1 being significant 
 
 
 
 
 
 
Table 8. P-values of Two-Way ANOVA of mRNA 
expression of β-catenin and TFRC in Surface and 
Crypt Niches. 
 
β-catenin 
Crypt 
β-catenin 
Surface 
TFRC 
Crypt 
TFRC 
Surface 
Interaction 0.07 0.59 0.71 0.90 
Diet (a) 0.30 0.11 0.32 0.94 
Treatment (b) 0.03 0.44 0.27 0.62 
a=p-values of the effect of the diet with p<0.1 being significant 
b=p-values of the effect of either saline or AOM injection with p<0.1 being significant 
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ABSTRACT 
 
Aberrant Wnt signaling is common in colorectal cancer, with a key feature being mis-regulation 
and over-expression of β-catenin, an intracellular signal transducer of the Wnt signaling pathway 
by colonocytes.  Resistant starches (RS), the portion of non-digestible starch, have been 
suggested to reduce colon cancer through production of short chain fatty acids (SCFAs) by the 
colonic microflora and their fermentation process.  Butyrate, a SCFA produced by the microbial 
fermentation, assists in maintaining the colonic epithelial proliferation through undefined 
interactions with the apoptotic and Wnt signaling pathways.  We hypothesize that an increase in 
dietary resistant starch will modulate the action of the Wnt pathway in colonic crypt epithelial 
cells.  We evaluated mRNA levels of β-catenin and other key genes in the Wnt pathway in 
colonic crypt epithelial cells, comparing results from A/J mice fed diets containing novel 
resistant starches. Diets contained a high-amylose cornstarch (HA7), high-amylose 7 complexed 
with octenyl-succinic anhydride RS (OS-HA7), high amylose 7 complexed with a stearic acid 
lipid (SA-HA7), or commercially available corn starch (CS), with 19.0 ±1.8% , 4.7±0.4%, 
31.1±1.7%, and 3.7±0.7% digestion resistance, respectively. Carcinogenesis was initiated by 4 
weekly IP injects of azoxymethane (AOM) at a 7.5mg/kg dose prior to feeding diets containing 
resistant starch.  Dietary and treatment controls included the commercially available corn starch, 
CS, and saline injection, respectively. Populations of histologically normal epithelial cells of the 
crypt base were collected by laser microdissection and quantitative PCR performed for genes and 
targets of the Wnt pathway.  Results demonstrate that a diet containing highly resistant starch 
results in a normalizing effect on upstream genes of the Wnt signaling pathway, and that resistant 
starch therefore has the potential to effectively inhibit the activity of the Wnt signaling pathway.  
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INTRODUCTION 
 
 Colorectal cancer is the third most commonly diagnosed cancer in both men and women 
with approximately 102,480 new cases of colon cancer in the USA in 2013 alone (Society, 
2013).  Altering the microbiome through the use of dietary preventative measures, such as 
prebiotics and other food sources, have been shown to help maintain normal colonic epithelium 
and reduce the incidence of this disease (Clausen, et al., 1991; Lattimer and Haub, 2010).   
 Dietary resistant starch (RS) is starch or parts of starch molecules that are not digested in 
the small intestine and instead are available for fermentation in the colon.  Fermentation by the 
colonic microbiota produces metabolic products such as short chain fatty acids, including 
butyrate, which have been shown, through unknown mechanisms, to reduce the development of 
colon cancer (O'Keefe, et al., 2009; Scharlau, et al., 2009). Dietary resistant starch shows 
promise as a prebiotic for preventing colorectal cancer by modifying genes needed for 
proliferation and maturation of cells in colonic crypts, the site of intestinal mucosal renewal 
(Fung, et al., 2012).   
 There are currently 5 types of resistant starch, with each type representing a different 
mechanism of resistance.  Type two resistant starch (RS2) is starch that occurs in its natural 
granular form and commonly contains a high amylose content.  This study used HA7 (high-
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amylose starch VII, a type 2 RS).  Type four resistant starches (RS4) are starches that have been 
chemically modified to resist digestion and are not found naturally.  This study used OS-HA7, a 
high-amylose 7 cornstarch complexed with octenyl succinic acid and resists digestion through its 
hydrophobic tail complex.  Type five resistant starch (RS5) is a high-amylose 7 cornstarch 
complexed with a stearic acid to result in an amylose-lipid complex (Hasjim, et al., 2010).  This 
RS5 starch is designated SA-HA7 (high amylose 7-stearic acid complex) to denote its HA7 
origins and resists digestion due to the lipid complexing.  Each of these starches will affect the 
colonic microbiome differently (Birt and Phillips, 2013) and each starch is expected to have a 
unique effect on control of cell proliferation and differentiation through the Wnt signaling 
pathway, resulting in differential effects on carcinogenesis in the colon. 
 The Wnt signaling pathway is a critical regulator of normal colonic epithelial maturation 
and differentiation, with de-regulation of this pathway implicated in the development of 
colorectal cancer.  This pathway may be regulated by butyrate and other products of colonic 
microbial fermentation of resistant starch, in a molecular mechanism not fully understood (Fung, 
et al., 2012).   The Wnt signaling pathway acts in the stem cells and progenitor cells deep within 
the colonic epithelial crypts (Reya and Clevers, 2005).  In a cancerous state, the Wnt signaling 
pathway is activated, with the cascade initiated when one of the 16 recognized Wnt 
glycoproteins binds to Frizzled (Fz) or one of the Secreted Frizzled Related Proteins (SFRP) 
(Polakis, 2000; Huelsken, 2002).  Ligation either Fz or SFRP causes Axin, with the help of APC, 
to bind to and phosphylorate Dishevelled (DSH).  APC and Axin bind to GSK3-β, which, in an 
unbound state is able to bind to β-catenin and signal it for degradation.  This binding of GSK3-β 
by Axin thus allows β-catenin to accumulate in the cytoplasm and translocate to the nucleus 
(Polakis, 2000; Huelsken, 2002).  Once in the nucleus, β-catenin binds to the LEF/TCF complex 
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and transcribes many target genes (Cadigan and Nusse, 1997; Cadigan and Liu, 2005).  These 
targets include Axin1 and TFRC, which function in assisting to stabilize β-catenin and in the 
uptake of cellular iron, respectively.  Each of these target genes is required for cell proliferation 
and differentiation and their expression will further enhance the rate of proliferation of cells 
(Leung, et al., 2002; Rohrs, et al., 2009).  This becomes a positive feedback loop, allowing cells 
to accumulate β-catenin in the cytoplasm. 
 In the non-canonical pathway, Wnt proteins do not bind to the Frizzled receptors.  This 
lack of binding allows Axin and APC to bind to β-catenin and recruit GSK3-β to phosphylorate 
β-catenin (Holcombe, et al., 2002; Reya and Clevers, 2005).  Because of this phosphyloration, β-
catenin is degraded and cytoplasmic accumulation is prevented.  Subsequently, Wnt target genes 
are not transcribed and cells are not stimulated to divide, due to lack of a positive growth signal 
(Dienz and Clevers, 2000; de Sousa, et al., 2011).   
 The cells become more differentiated as they migrate up the crypt wall, and they are no 
longer acted on by Wnt signal as it is too weak to transfer from cell to cell to reach the topmost 
cells.  When they reach the upper portions of the crypts, these terminally differentiated cells are 
unable to initiate cell proliferation through β-catenin nuclear transduction (Nusse, 2008).  
Specifically evaluating gene expression in epithelial cells of the colonic crypt, the site of 
proliferation, is important as the Wnt signaling pathway does not act on other cell populations.   
 We hypothesized that the microbial fermentation products of resistant starch, SCFAs, 
which have been shown to be beneficial in inhibiting colorectal cancer through an undetermined 
mechanism, will be able to effectively control the Wnt signaling pathway, regulating 
proliferation of normal and pre-neoplastic (initiated) colonic crypt epithelial cells. 
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MATERIALS AND METHODS 
Diets.  This study used three different types of resistant starches, HA7, OS-HA7, and SA-HA7, 
each from a single processing batch and a readily digestible, commercially available cornstarch 
(CS) as a control.  HA7 is a high amylose 7 cornstarch classified as type two resistant starch, OS-
HA7 is a high amylose 7 cornstarch complexed with octenyl succinic acid and is classified as a 
type four resistant starch, and SA-HA7 (Resistant Starch type 5) is a high amylose 7 cornstarch 
complexed with stearic-acid (Hasjim, et al., 2010).  The four diets, containing HA7, OS-HA7, 
SA-HA7, and CS starches, were cooked by a water-boiling method and mixed with the 
remaining components of the diet (Zhao, et al., in press 2014).  The diet formulation was based 
on the American Society for Nutritional Sciences' standard diet recommendations for mature 
mice (AIN-93M) (Reeves, 1997).  The 5% cellulose in the AIN-93M diet was not included and 
instead, the starch content was increased an extra %5 for a total of 55% starch content (Table1).  
All diets were made fresh and fed every two days while the control diets were fed every other 
day, to preserve freshness, once the experimental diets were fed.  The resistant starch contents of 
the starches and diets were measured fresh by both the Englyst Method and AOAC Method 
991.43 (Englyst, 1986; Horwitz, 2003).   The water content of these samples was determined by 
a Sartorius moisture analyzer MA30 (Bohemia, NY).  Both the resistant starch and water 
contents are listed in Table 2. 
 
Animals and Housing. A total of 60, 5-week-old, male A/J mice were received from Jackson 
Laboratory (Bar Harbor, Maine).  The mice were individually housed in plastic cages with 
stainless-steel, wire-mesh tops.  Additionally, stainless-steel wire floors were also placed in the 
cages to prevent coprophagia during the time the four experimental diets were fed.  The room 
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was kept at 22±1ºC with 60±5% humidity with a 12-hour light cycle.  Diet and water were 
available ad libitum.  The animal studies were approved by and performed in compliance with 
the Institutional Animal Care and Use Committee of Iowa State University.  The mice were 
randomly assigned to four diet groups (Control, HA7, OS-HA7, and RS5) with 15 mice in each 
group. 
 
Carcinogen Treatment.  Azoxymethane (AOM) was purchased from Midwest Research 
Institute (Kansas City, MO) and injected intraperitoneally once a week for four weeks into 10 
mice from each diet group at an 7.5mg AOM/kg mouse body weight dosage.  The remaining 5 
mice from each diet group received intraperitoneal injections of physiological saline, as a 
negative control. 
 
Diet Treatment.  All mice were placed on a semi-purified control diet from arrival to three days 
after the last AOM injection.  The mice were then divided randomly into their treatment groups 
and fed the respective diets for 10 weeks. Body weights were measured weekly and food 
disappearance was measured by calculating the difference between the food presented to each 
animal and the amount left over at the end of each feeding.  Food disappearance is a rough 
measure as moisture content varies from food presented to that left over which affects weight.  
 
Necropsy and tissue sampling.  Immediately following euthanasia, the colon was removed, 
incised longitudinally, fecal material gently removed, and the colon was spiraled and frozen in a 
cassette with O.C.T (Optimal Cutting Temperature) compound (VWR, Radnor, PA).  Tissues 
were stored at -80OC until frozen sectioning.   
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Microdissection and RNA collection and processing.  Blocks of tissue were equilibrated to -
20OC and tissues sectioned to 10 microns, using a cryostat microtome, with chuck and cabin 
maintained at -20OC.  Tissue sections were collected onto SuperfrostPlus microscope slides and 
placed at -80OC until staining and laser microdissection was performed. Tissue sections were 
stained in small groups using the Arcturus HistoGene LCM frozen section staining kit (Life 
Technologies, Grand Island, NY) and stored in xylene until laser microdissection was performed.  
A PixCell II Laser Capture Microdissection System (Life Technologies, Grand Island, NY) was 
used to isolate epithelial cells of the deep region of the crypt, up to the +3 cells.  Only 
microdissected cells of the colonic crypts were collected, to prevent an averaging of mRNA 
expression levels by other cell types as is the case in a whole tissue analysis.  Cells were 
collected uniformly from all regions of the colon.  RNA extraction was performed according to 
the PicoPure RNA Isolation protocol (Life Technologies, Grand Island, NY)  using the DNA 
nuclease kit (QIAGEN, Valencia, CA).  A Nanodrop 1000 Spectrophotometer (Thermo 
Scientific, Wilmington, DE) was used to confirm the quantity and quality of the isolated RNA.   
  
Semi-qualitative real-time PCR.  Reverse transcription was performed on the DNA-free RNA 
collected from the epithelial crypts of the colon using iScript cDNA synthesis kit (BioRad, 
Hercules, CA).  Six genes (β-catenin, APC, Wnt 5a, Axin1, SFRP4, and TFRC) were selected for 
quantitative real-time PCR analysis (qRT-PCR) to investigate changes in the regulation of the 
Wnt signaling pathway among the different diets (Control, HA7, OS-HA7, and RS5) and 
treatments (Saline v AOM) (Table 3).  GAPDH was used as a reference gene as our pilot studies 
demonstrated relatively uniform expression of this gene as compared with PSMB6 and PMM1 
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(data not shown), which was in accordance with previous reports (Rubie, et al., 2005).  Primer 
Quest software (Integrated DNA Technologies, Inc., Coralville, IA) was used to design the 
primers for qRT-PCR and were synthesized by Integrated DNA Technologies, Inc.  SYBR Green 
Supermix kit (BioRad, Hercules, CA) was used for the qRT-PCR procedure according to the 
manufacturer's instructions.  A GeneAmp 5700 Sequence Detection System was used with 
conditions of 95 °C for 3 min, and 45 cycles of 95 °C for 15 s, annealing temperature of the 
primer for 30 s, and 72 °C for 30 s, followed by 95 °C for 1 min, and 55 °C for 1 min.   
 
Statistical Analysis.  Body weight data for weeks 0 to 6 were analyzed using simple linear 
regression (weight to week) to get the slope coefficient for each mouse and then the student's t-
test was applied to compare the slope coefficients for the saline and AOM groups. For weeks 6 
to 16, the weight gain for each mouse was first calculated, and then ANOVA (overall F-test) 
was used to compare the average weight gain among the 8 groups.  ∆Cq values from PCR data 
from crypt epithelial populations were calculated (Bustin, et al., 2009; Lefever, et al., 2009).  
∆∆Cq values used to calculate fold-change as described by Pfaffl et al. (Table 5).  Differences in 
∆Cq values were analyzed using Two-Way ANOVA with post-test (Two-way analysis of 
variance and Tukey’s multiple comparison test for normally distributed data or Kruskal-Wallis 
test and Dunn’s multiple comparison test for data that was not normally distributed) (Table 4) 
and Student's t-tests.   All values were reported as mean + standard deviation with the exception 
of fold change.  A p-value < 0.1 was considered significant due to low sample volume (Casson, 
et al., 2005; Cai and Lashbrook, 2006).  Data analysis was performed using SAS and/or 
GraphPad Prism. 
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RESULTS 
Resistant Starch Content of the Experimental Diets.  Resistant starch content of the Control, 
HA7, OS-HA7, and SA-HA7 diets based on the dry diet weight of the diets are listed in Table 2.  
The contents were calculated using both the AOAC 991.43and Englyst Methods.  The water 
content of each of the four diets was 12±0.2% (Table 2). 
 
Body Weight.  The body weights of the mice were statistically different when comparing the 
data from weeks 0-6, before diets were started, between the AOM- and saline-treated mice 
(p<0.0001) with the AOM-injected mice weighing less than the saline-injected mice.  After the 
mice were placed on their respective diets, the total weight gains among diet and treatment 
groups were significantly different (p<0.001).  The mice fed control diet were the heaviest, with 
those injected with AOM weighing significantly less than those injected with saline.  The mice 
fed the OS-HA7 diet weighed the least, with mice fed this diet and injected with saline weighing 
more than those injected with AOM (Figure 1).  
 
Expression of Wnt pathway genes by deep-crypt colonocytes.  β-catenin mRNA expression 
was decreased among all AOM-treated mice compared with the saline counterparts within the 
CS, HA7, and OS-HA7 diets, with the decrease in the mice fed the OS-HA7 diet being 
significant (p=0.02).  The AOM-treated mice fed the SA-HA7 diet had somewhat higher β-
catenin mRNA expression than the saline-treated mice fed the SA-HA7 diet (p=0.14).  The 
AOM-treated mice fed the OS-HA7 diet also had a significantly decreased mRNA expression of 
β-catenin when compared with the CS-fed mice injected with AOM (p=0.08) (Figure 2A).  APC 
mRNA expression is relatively stable when comparing results between AOM-treated and saline-
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treated mice within each diet. The AOM-treated mice fed the OS-HA7 diet also had a 
significantly increased mRNA expression of APC when compared with the CS-fed mice injected 
with AOM (p=0.003) (Figure 2B).  Expression of Wnt 5a mRNA was somewhat increased in the 
AOM-treated mice compared to the saline-treated mice within the OS-HA7 diet (p=0.14).  The 
AOM-treated mice fed the OS-HA7 diet had a significantly increased mRNA expression of Wnt 
5a when compared to the CS-fed mice injected with AOM (p=0.004).  Expression was, however, 
somewhat decreased in the AOM-treated mice compared to the saline treated mice within the 
SA-HA7 diet (p=0.12) (Figure 2C).  Axin 1 mRNA expression demonstrates varying mRNA 
levels with mice injected with AOM displaying an increased expression compared to saline-
injected mice among the CS (p=0.28) and SA-HA7 (p=0.09) fed mice.  The saline-treated mice 
fed the OS-HA7 diet had an almost significantly increased mRNA expression of Axin 1 when 
compared with the CS-fed mice injected with saline (p=0.11) (Figure 2D).  SFRP4 mRNA 
expression was increased in the AOM-treated mice fed both the OS-HA7 and SA-HA7 diets 
when compared with the CS-fed mice injected with AOM (p=0.03 and p=0.09, respectively) 
(Figure 2E).  There were no significant differences in ∆Cq results for mRNA encoding TFRC 
when comparing AOM-injected mice to saline-injected mice or when comparing data between 
diet groups (Figure 2F).   
 
DISCUSSION   
 The inclusion of a highly resistant starch, SA-HA7, in the diet of mice in the 
preneoplastic stage of colon cancer resulted in a significant increase in β-catenin mRNA levels in 
the colonic epithelium.  While a large body of evidence demonstrates that increased β-catenin 
mRNA levels are indicative of an active Wnt signaling pathway (Polakis, 1999; Polakis, 2000; 
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Hirose, et al., 2003; Feng Han, et al., 2006; Segditsas and Tomlinson, 2006), recent research may 
change the way in which we think about this pathway.  Kwon et al., recently proposed an 
alternate model in which increased expression of β-catenin mRNA may instead induce post-
translational modifications of β-catenin.  These modifications are then hypothesized to inhibit 
proliferation of stem and progenitor cell populations through the Notch signaling pathway 
(Kwon, et al., 2011). This alternative model correlates to our mRNA expression data of other key 
genes, Wnt 5a and Axin1, in the Wnt signaling pathway, which also point toward a potentially 
inactive state of the Wnt signaling pathway in SA-HA7-fed rats injected with AOM.  However, 
our parallel studies showed the highest number of potentially pre-cancerous lesions in the SA-
HA7 group, trending toward significance (Nelson, et al., unpublished). 
 The inclusion of a resistant starch with a relatively low level of resistance, OS-HA7, in 
the diet of AOM-initiated mice resulted in a significant decrease in β-catenin mRNA expression, 
which commonly is indicative of an inactive Wnt pathway (Polakis, 1999).  In contrast, it is 
possible that a secondary mechanism, acting through post-translational modifications of β-
catenin by Notch signaling, is interacting with and regulating the β-catenin mRNA expression 
(Kwon, et al., 2011).  This alternative model correlates to our mRNA expression data of other 
key genes, APC, Wnt 5a and SFRP4, in the Wnt signaling pathway, which suggest an active state 
of the Wnt signaling pathway in OS-HA7-fed rats injected with AOM. 
 The resistant starch content of each diet was measured by both the AOAC 991.43 and 
Englyst Method as the AOAC 991.43 method does not measure the resistant starch content of the 
OS-HA7 diet as effectively as that of the Englyst Method, although no single method has been 
shown to be completely accurate (Ai, et al., 2013).  The SA-HA7 diet was confirmed to have a 
statistically higher resistant starch content (p<0.05) than all other diets used in this study, which 
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may be causing enhanced fermentation in the mice fed this diet, probably due to increased 
amounts of starch available for the colonic microbiota to use as a food source. 
 The mice injected with AOM weighed significantly less than control mice injected with 
saline (p<0.05).  At the time of injections, all mice were fed the highly digestible, commercially 
available cornstarch diet.  Injection of AOM, a chemical carcinogen, is a stressful event for mice.  
A decrease in bodyweight of the mice demonstrates that they are reacting to the chemical 
carcinogen (Bissahoyo, et al., 2005; Suzuki, et al., 2006; Chen and Huang, 2009; De Robertis, et 
al., 2011).  The mice did regain the lost weight and further increased weights after injections 
ceased demonstrating that the mice were able to thrive on these diets.  After AOM or saline 
injections, mice were randomly divided into four diet groups, resulting in eight total groups of 
mice (a group of AOM-injected and a group of saline-injected mice per each diet group).  The 
weight gain difference (weight at sacrifice minus the weight of the mice at start of the four diets) 
was statistically different among all eight groups (p<0.05) (Figure 1).  The use of azoxymethane 
has also been shown to initiate the Wnt signaling pathway and cause an increase in cell 
proliferation (Hirose, et al., 2003; Takahashi and Wakabayashi, 2004; Chen and Huang, 2009). 
In our study, we observed no significant changes in gene expression, comparing AOM-injected 
with saline-injected, among the control diet-fed mice for any of the genes selected.    
 Diets containing moderate or high levels of resistant starch were able to modify mRNA 
expression of genes of the Wnt signaling pathway. OS-HA7 starch fed to AOM-injected mice 
increased APC, Wnt 5a, and SFRP4 mRNA levels relative to the CS-fed mice injected with 
AOM (p=0.003, p=0.004, and p=0.03, respectively).  The mRNA expression levels of many of 
these genes were not only up-regulated when comparing with the control-fed mice, but also 
when comparing saline-injected mice with AOM-injected mice within the OS-HA7 diet.  
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Expression of Wnt 5a, SFRP4, and TFRC mRNA levels were somewhat increased in the AOM-
injected mice fed the OS-HA7 diet relative to those injected with saline (p=0.14, p=0.17, and 
p=0.19, respectively).  β-catenin mRNA expression was decreased in the AOM-injected mice fed 
the OS-HA7 diet relative to those injected with saline (p=0.02).  The ability of the OS-HA7 diet 
to somewhat increase mRNA expression of Wnt 5a, SFRP4, and TFRC suggests that OS-HA7 
fed in the diet may be able to up-regulate the Wnt signaling pathway in an initiated-state.  While 
β-catenin mRNA expression suggests a down-regulation of the Wnt signaling pathway in AOM-
injected mice, it is possible that another un-identified underlying mechanism is interacting with 
members of the Wnt pathway and regulating β-catenin mRNA expression.  This study focused on 
the very earliest, preneoplastic stage of colon cancer, initiation, but the ability of a moderately 
resistant starch, OS-HA7, in the diet to increase mRNA expression levels show the potential to 
enhance cell proliferation (Fujise, et al., 2006; Kim and Milner, 2007).  
 A highly resistant starch, SA-HA7, created by conjugating stearic acid to a high amylose 
starch, in the diet has also demonstrated the ability to effectively decrease mRNA expression of 
genes in the Wnt pathway in crypt epithelial cells of the colon.  SA-HA7 fed in the diet has 
demonstrated an ability to somewhat reduce Wnt5a mRNA expression in AOM-injected mice 
relative to those injected with saline (p=0.12).  Mice injected with AOM also have an increased 
Axin1 mRNA expression compared with those injected with saline among the SA-HA7 diet 
group (p=0.09).  Both of the mRNA expression levels demonstrate some ability of the SA-HA7 
diet to down-regulate the Wnt signaling pathway.  However, SA-HA7 fed in the diet of mice 
injected with AOM had a somewhat increased β-catenin mRNA expression relative to the saline-
injected mice fed the SA-HA7 diet (p=0.14).  Historically, increased β-catenin levels have been 
shown to be indicative of an active Wnt signaling pathway, but this data does not correspond to 
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the mRNA expression of other genes tested.  However, this data does correlate to parallel studies 
demonstrating the greatest ACF in the SA-HA7 fed mice injected with AOM (Nelson, et al., 
unpublished).  This increase in β-catenin mRNA levels does correspond to the expression data of 
other genes if a recently proposed alternate model, in which increased expression of β-catenin 
mRNA may instead induce post-translational modifications of β-catenin, is used.  The 
modification of β-catenin would then inhibit proliferation of stem and progenitor cells through 
the Notch signaling pathway (Kwon, et al., 2011). This alternative model more readily correlates 
to our mRNA expression data of other key genes in the Wnt signaling pathway, which also point 
toward a potentially inactive state of the Wnt signaling pathway in SA-HA7-fed mice injected 
with AOM.  This result has also been supported by other research suggesting certain types of 
dietary resistant starch inhibit Wnt signaling activity (Wollowski, et al., 2001; Fujise, et al., 2006; 
Kim and Milner, 2007; Nofrarias, et al., 2007; Fung, et al., 2012).  Though this alternate model 
does not correlate to ACF results by Nelson et. al., the validity of ACF as a preneoplastic lesion 
has recently come in to question (Hirose, et al., 2003). 
 Overall, these results demonstrate that the OS-HA7 diet, containing a low level of 
resistant content, was able to up- and down-regulate the expression of the mRNA for β-catenin, 
APC, Wnt 5a, SFRP4, and TFRC of the Wnt signaling pathway in the stem cell niche.  This 
suggests that a low level of resistant starch content may not slow cell proliferation and 
differentiation and may instead increase cell proliferation, which may potentiate the development 
of colorectal cancer. 
 On the other hand, the results also demonstrate that the SA-HA7 diet, containing a high 
amount of resistant starch, has the potential to effectively modify the expression of mRNA 
encoding genes for β-catenin, Wnt 5a, and Axin 1 in the colonic crypt cells.  With the exception 
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β-catenin mRNA expression, all data suggest an ability of SA-HA7 fed in the diet to inhibit the 
Wnt signaling pathway.  An alternate model has been recently proposed in which increased 
expression of β-catenin mRNA induces post-translational modifications of β-catenin is able to 
inhibit proliferation of stem and progenitor cells through the Notch signaling pathway.  If this 
model is considered, then the increase β-catenin mRNA expression seen in this study may also 
be indicative of a down-regulated Wnt signaling pathway in an AOM-induced state.  This 
suggests an ability of resistant starch to decrease the mRNA expression of key genes of the Wnt 
signaling pathway. 
 This study demonstrates the importance of the percentage of resistant content in the diet, 
as these four diets, with significantly different resistant starch contents, gave very different ∆Cq 
results.  Our studies suggest that enhanced intake of high content resistant starch has the potential 
to help to inhibit the Wnt signaling pathway and provide many health benefits, while a low 
content of resistant starch may actually have harmful effects.  The genes in these studies may 
also be prospective targets for the prevention of colorectal cancer, with future studies needed to 
investigate the effects of both AOM and diet on the protein levels of the Wnt signaling pathway. 
 
ABBREVIATIONS 
AOM, Azoxymethane  
RS, Resistant Starch 
HA7, High-Amylose 7 starch diet 
OS-HA7, Octenyl succinate acid starch diet 
SA-HA7, Stearic acid complexed starch diet 
CRC, Colorectal cancer 
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LCM, Laser Capture Microdissection 
O.C.T, Optimal Cutting Temperature 
 
SAFETY 
 Azoxymethane is a potent carcinogen used experimentally to induce colon cancer in rats 
and mice. It might cause harm to human if swallowed, inhaled, or absorbed through skin. 
 
ACKNOWLEDGEMENTS 
 This research was funded by Plant Sciences Institute at Iowa State University and the 
United States Department of Agriculture (USDA) NRI/AFRI Project “Effects of lipids on 
physical properties, digestibility and nutritional benefits of starchy foods.”  We appreciate the 
contributions of Toni Christofferson for histopathology processing and sectioning, Margie Carter 
for assistance with LCM, and to Dr. Angela Pillatzki for assisting in optimizing research 
protocols.  We include a very special thank you to Reed Faldet, Catie Mullen, Dana Pralle, and 
Kylie Thompson for the extensive help with the care of the mice. 
 
 
 
REFERENCES 
Ai, Y., Nelson, B., et al. (2013). "In vitro and in vivo digestion of octenyl succinic starch." 
Carbohydr Polym 98(2): 1266-1271. 
Birt, D. F. and Phillips, G. J. (2013). "Diet, Genes, and Microbes: Complexities of Colon Cancer 
Prevention." Toxicol Pathol. 
Bissahoyo, A., Pearsall, R. S., et al. (2005). "Azoxymethane is a genetic background-dependent 
colorectal tumor initiator and promoter in mice: effects of dose, route, and diet." Toxicol 
Sci 88(2): 340-345. 
Bustin, S. A., Benes, V., et al. (2009). "The MIQE guidelines: minimum information for 
publication of quantitative real-time PCR experiments." Clin Chem 55(4): 611-622. 
92 
 
 
 
Cadigan, K. M. and Liu, Y. I. (2005). "Wnt Signaling: Complexity at the Surface." Journal of 
Cell Science 11: 395-402. 
Cadigan, K. M. and Nusse, R. (1997). "Wnt signaling: a common theme in animal development." 
Genes & Development 11(24): 3286-3305. 
Cai, S. and Lashbrook, C. C. (2006). "Laser capture microdissection of plant cells from tape-
transferred paraffin sections promotes recovery of structurally intact RNA for global gene 
profiling." Plant J 48(4): 628-637. 
Casson, S., Spencer, M., et al. (2005). "Laser capture microdissection for the analysis of gene 
expression during embryogenesis of Arabidopsis." Plant J 42(1): 111-123. 
Chen, J. and Huang, X. F. (2009). "The signal pathways in azoxymethane-induced colon cancer 
and preventive implications." Cancer Biol Ther 8(14): 1313-1317. 
Clausen, M. R., Bonnen, H., et al. (1991). "Colonic fermentation of dietary fibre to short chain 
fatty acids in patients with adenomatous polyps and colonic cancer." Gut 32(8): 923-928. 
De Robertis, M., Massi, E., et al. (2011). "The AOM/DSS murine model for the study of colon 
carcinogenesis: From pathways to diagnosis and therapy studies." J Carcinog 10: 9. 
de Sousa, E. M., Vermeulen, L., et al. (2011). "Targeting Wnt signaling in colon cancer stem 
cells." Clin Cancer Res 17(4): 647-653. 
Dienz, M. and Clevers, H. (2000). "Linking Colorectal Cancer to Wnt Signaling." Cell 103: 311-
320. 
Englyst, H. N., and Macfarlane, G.T. (1986). "Breakdown of Resistant and Readily Digestible 
Starch by Human Gut Bacteria." Journal of the Science of Food Agriculture 37: 699-706. 
Feng Han, Q., Zhao, W., et al. (2006). "Expression of sFRP-4 and beta-catenin in human 
colorectal carcinoma." Cancer Lett 231(1): 129-137. 
Fujise, T., Iwakiri, R., et al. (2006). "Long-term feeding of various fat diets modulates 
azoxymethane-induced colon carcinogenesis through Wnt/Beta-Catenin signaling in 
rats." Am J Physical Gastrointest Liver Physiol. 
Fung, K. Y., Cosgrove, L., et al. (2012). "A review of the potential mechanisms for the lowering 
of colorectal oncogenesis by butyrate." Br J Nutr 108(5): 820-831. 
Hasjim, J., Lee, S.-O., et al. (2010). "Characterization of a Novel Resistant-Starch and Its Effects 
on Postprandial Plasma-Glucose and Insulin Responses." Cereal Chemistry 87(4): 257-
262. 
Hirose, Y., Kuno, T., et al. (2003). "Azoxymethane-induced beta-catenin-accumulated crypts in 
colonic muscosa of rodents as an intermediate biomarker for colon carcinogenesis." 
Carcinogenesis 24(1): 107-111. 
93 
 
 
 
Holcombe, R. F., Marsh, J. L., et al. (2002). "Expression of Wnt ligands and Frizzled receptors 
in colonic mucosa and in colon carcinoma." Mol Pathol 55(4): 220-226. 
Horwitz, W. a. ( 2003). Official Methods of Analysis of AOAC International - 17th Edition 
Revision 2, Association of Official Analytical Chemists. 
Huelsken, J. (2002). "The Wnt signalling pathway." Journal of Cell Science 115(21): 3977-3978. 
Kim, Y. S. and Milner, J. A. (2007). "Dietary modulation of colon cancer risk." J Nutr 137(11 
Suppl): 2576S-2579S. 
Kwon, C., Cheng, P., et al. (2011). "Notch post-translationally regulates beta-catenin protein in 
stem and progenitor cells." Nat Cell Biol 13(10): 1244-1251. 
Lattimer, J. M. and Haub, M. D. (2010). "Effects of dietary fiber and its components on 
metabolic health." Nutrients 2(12): 1266-1289. 
Lefever, S., Hellemans, J., et al. (2009). "RDML: structured language and reporting guidelines 
for real-time quantitative PCR data." Nucleic Acids Res 37(7): 2065-2069. 
Leung, J. Y., Kolligs, F. T., et al. (2002). "Activation of AXIN2 expression by beta-catenin-T 
cell factor. A feedback repressor pathway regulating Wnt signaling." J Biol Chem 
277(24): 21657-21665. 
Nelson, B., Ai, Y., et al. (unpublished). "Effect of dietary resistant starch on preneoplasia in 
azoxymethane induced rodent models." 
Nofrarias, M., Martinez-Puig, D., et al. (2007). "Long-term intake of resistant starch improves 
colonic mucosal integrity and reduces gut apoptosis and blood immune cells." Nutrition 
23(11-12): 861-870. 
Nusse, R. (2008). "Wnt signaling and stem cell control." Cell Res 18(5): 523-527. 
O'Keefe, S. J., Ou, J., et al. (2009). "Products of the colonic microbiota mediate the effects of 
diet on colon cancer risk." J Nutr 139(11): 2044-2048. 
Polakis, P. (1999). "The oncogenic activation of beta-catenin." Curr Opin Genet Dev 9(1): 15-21. 
Polakis, P. (2000). "Wnt signaling and cancer." Genes Dev 14(15): 1837-1851. 
Reeves, P. G. (1997). "Components of the AIN-93 diets as improvements in the AIN-76A diet." 
Journal of Nutrition 127: S838-S841. 
Reya, T. and Clevers, H. (2005). "Wnt signalling in stem cells and cancer." Nature 434(7035): 
843-850. 
Rohrs, S., Kutzner, N., et al. (2009). "Chronological expression of Wnt target genes Ccnd1, Myc, 
Cdkn1a, Tfrc, Plf1 and Ramp3." Cell Biol Int 33(4): 501-508. 
94 
 
 
 
Scharlau, D., Borowicki, A., et al. (2009). "Mechanisms of primary cancer prevention by 
butyrate and other products formed during gut flora-mediated fermentation of dietary 
fibre." Mutat Res 682(1): 39-53. 
Segditsas, S. and Tomlinson, I. (2006). "Colorectal cancer and genetic alterations in the Wnt 
pathway." Oncogene 25(57): 7531-7537. 
Society, A. C. (2013). "American Cancer Society." from www.americancancersociety.org. 
Suzuki, R., Kohno, H., et al. (2006). "Strain differences in the susceptibility to azoxymethane 
and dextran sodium sulfate-induced colon carcinogenesis in mice." Carcinogenesis 27(1): 
162-169. 
Takahashi, M. and Wakabayashi, K. (2004). "Gene mutations and altered gene expression in 
azoxymethane-induced colon carcinogenesis in rodents." Cancer Sci 95(6): 475-480. 
Wollowski, I., Rechkemmer, G., et al. (2001). "Protective role of probiotics and prebiotics in 
colon cancer." Am J Clin Nutr 73(2 Suppl): 451S-455S. 
Zhao, Y., Ai, Y., et al. (in press 2014). "Inhibition of Azoxymethane-induced Preneoplastic 
Lesions in the Rat Colon by a Stearic Acid Complexed High-amylose Cornstarch using 
Different Cooking Methods and Assessing Potential Gene Targets." Journal of Functional 
Foods. 
 
 
  
95 
 
 
 
FIGURE LEGENDS 
 
Figure 1. Graph of bodyweights of each treatment group.  Each AOM group contained 10 
mice, whereas each saline groups contained 5 mice, with the exception of CS-Saline (n=4).  
*represents statistical significant differences of the OS-HA7 group injected with AOM compared 
with both the OS-HA7 group injected with saline and the CS group injected with AOM from the 
start of the experimental diets (week 7) until sacrifice (week 17), with only weeks 8, 12, and 17 
marked as a representation. 
 Figure 2A-F. mRNA expression of Wnt pathway-related genes in the colonic crypt of mice 
fed diets containing CS, HA7, OS-HA7, or SA-HA7 starches.  Data reported are ∆Cq 
values, using the ∆∆Cq method.  Each AOM group had n=10 while each saline group had n=5 
with the exception of CS-saline which had n=4.  Bars represent statistical significance with one 
star (*) representing= p-value <0.1 and two stars (**) represent= p<0.05.  + bars represent a 
trend toward statistical significance (p<0.12).  P-values of the Two-Way ANOVA analysis for 
each mRNA species are listed in Table 5. 
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FIGURES 
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TABLE LEGENDS 
Table 1. Diet Ingredients. Components of the starch diet as characterized by Zhao, et al. (in 
press 2014). 
Table 2. Resistant Starch and Water Content of Starches and Diets.  Percentage resistant 
starch content of the diet was determined using the both the AOAC method 991.43 and the 
Englyst Method. 
Table 3.  Primer Sequences for Quantitative RT-PCR of Mouse Colon Samples. 
Table 4. Modulation of mRNA expression of genes of the Wnt pathway by dietary resistant 
starch in the colonic crypts of AOM-injected and control mice.  With comparisons made 
within and across diets ∆∆Cq method. *indicates statistical significance (p<0.1). 
Table 5. P-values of Two-Way ANOVA of genes of the Wnt pathway in colonic crypts. 
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TABLES 
 
 
Table 1: Diet Ingredients1. 
 
 
 
Diet Ingredient 
Diet 
Components 
 
 starch 55.0%  
 casein 20.0%  
 dextrose 15.0%  
 cellulose (insoluble fiber) 0.0%  
 mineral mix (AIN-93) 3.5%  
 choline 0.2%  
 methionine 0.3%  
 vitamin mix (AIN-93) 1.0%  
 corn oil 5.0%  
   
 
1.
 Diets were prepared as described in the text. All non-starch diet ingredients were purchased 
from Harland Teklad (Madison, WI) or Spectrum (Gardena, CA). 
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Table 2: Resistant starch and water contents of the diets. 
 
Starch 
Groups 
Resistant Starch Content of 
the Diets on a Dry Diet Basis 
Measured by AOAC method 
991.43 
Resistant Starch Content of 
the Diets on a Dry Diet Basis 
Measured by the Englyst 
Method 
Water Content 
of the Diets 
 
(n=2) (n=2) (n=2) 
 
(% + sd) (% + sd) (% ± sd) 
 
Control 3.7±0.7% 1.40 ± 0.39% 12± 0.2% 
HA7 19.0±1.8% 12.75 ± 0.20% 12± 0.2% 
OS-HA7 4.7±0.4% 15.28 ± 2.70% 12± 0.2% 
SA-HA7 31.1±1.7% 17.63 ± 0.59% 12± 0.2% 
Data are expressed as mean + SD.  
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Table 3.  Primer Sequences for Quantitative RT-PCR of Mouse Colon Samples 
 
Gene Name   Primer Sequence 
   
GAPDH  Forward TCAACAGCAACTCCCACTCTTCCA 
   Reverse ACCCTGTTGCTGTAGCCGTATTCA 
 
APC   Forward TGCACAACTTTGTTGCCCTTGGAG 
   Reverse TTCTGATGGCTCTCAACCAGGACA 
 
Axin1   Forward AGAAACACATGGTCATGCCAAGCC 
   Reverse TCCCAGATTCAGCCTTCTTGGTGT 
 
Beta-Catenin  Forward TGCAGCTTCTGGGTTCCGATGATA 
   Reverse AGATGGCAGGCTCAGTGATGTCTT 
 
SFRP 4  Forward TCATCACCAATTCCTCCTGCCAGT 
   Reverse TGTTCTCTGCTGTTCCTGAAGCCT 
 
TFRC   Forward TGAAACTGGCTGAAACGGAGGAGA 
   Reverse GCTGCTTGATGGTGTCAGCAAACT 
 
Wnt 5a  Forward ACTGGCAGGACTTTCTCAAGGACA 
   Reverse GCCTATTTGCATCACCCTGCCAAA 
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Table 4.  Modulation of mRNA expression of genes of the Wnt pathway by dietary resistant 
starch in the colonic crypt of AOM-injected and control mice.   
 
 
Effect of Dietary RS on gene expression in saline treated colon (b)  
  Diets (a) β-catenin APC Wnt 5a Axin 1 SFRP4 TFRC 
HA7 0.70 0.68 0.22 0.19 29.07 0.68 
OS-HA7 1.75 0.05 0.08 0.09 2.51 6.10 
SA-HA7 6.56 0.09 0.02 1.10 0.16 2.02 
a= animals not treated with AOM; ΔΔCqs calculated comparing test diets to control (CS) diet 
b= fold change 
       
        
        Effect of Dietary RS on gene expression in AOM-induced colon (b) 
 Diets (c) β-catenin APC Wnt 5a Axin 1 SFRP4 TFRC 
HA7 1.96 2.43 1.22 2.71 2.22 0.90 
OS-HA7 5.64* 0.06* 0.04* 1.09 0.05* 1.07 
SA-HA7 0.54 0.28 0.84 0.37 0.11* 4.08 
b= fold change  
c= animals treated with AOM; ΔΔCqs calculated comparing test diets to control (CS) diet 
        
        Effect of AOM-induction on gene expression in the colon (b) 
  Treatments (d) β-catenin APC Wnt 5a Axin 1 SFRP4 TFRC 
CS 1.20 0.35 0.30 0.23 2.22 1.89 
HA7 3.36 1.25 1.66 3.28 0.17 2.50 
OS-HA7 3.89* 0.38 0.13 2.79 0.04 0.33 
SA-HA7 0.10 1.13 12.61 0.08* 1.57 3.83 
b= fold change  
d= ΔΔCqs calculated comparing AOM-treatment with saline-treatment for each diet 
 
  
 
 
 
 
 
 
 
 
 
 
 
105 
 
 
 
 
 
 
 
Table 5.  P-values of Two-Way ANOVA of genes of the Wnt pathway 
in  colonic crypts 
 β-catenin APC Wnt 5a Axin 1 SFRP4 TFRC 
Interaction 0.22 0.90 0.20 0.27 0.59 0.83 
Diet (a) 0.65 0.01 0.06 0.78 0.09 0.67 
Treatment (b) 0.87 0.60 0.94 0.58 0.43 0.61 
a=p-values of the effect of the diet with p<0.1 being significant 
b=p-values of the effect of either saline or AOM injection with p<0.1 being significant 
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CHAPTER 4: GENERAL CONCLUSIONS 
General Discussion 
 With approximately 102,480 new cases of colon cancer in 2013, colorectal cancer (CRC) 
is the third most commonly diagnosed cancer in the USA alone (Society, 2013).  While the 
number of people dying from colorectal cancer has slowly begun to decline, due to an increased 
screening rate, the use of dietary preventative measures holds the possibility of drastically 
reducing the incidence of this disease (Clausen, et al., 1991; Lattimer and Haub, 2010).  Dietary 
resistant starch (RS) shows promise as a prebiotic agent for preventing colorectal cancer by 
modifying proliferation and maturation in colonic crypts, the site of intestinal mucosal renewal.   
 Resistant starch fermentation by colonic bacteria has been shown to be beneficial to 
human health (Cummings, et al., 1996).  Butyrate, a fermentation product, is a short-chain fatty 
acid known to have protective effects on the epithelium of the colon.  It has been shown to be 
able to inhibit DNA synthesis of neoplastic cells through inhibition of histone deacetylases 
(Nofrarias, et al., 2007; Fung, et al., 2012).  Butyrate and other products of colonic RS 
fermentation, in a molecular mechanism not fully understood, may regulate the Wnt signaling 
pathway.  This pathway plays a major role in mammalian development and maintains many 
tissues and organs by regulating cell proliferation, differentiation, and epithelial-mesenchymal 
interactions (Moon, et al., 1997; Smalley and Dale, 1999).  The Wnt pathway regulates and acts 
specifically on the stem cell populations, in each tissue, which lends to its role in initiation and 
progression of cancer, with colorectal and breast cancers being most influenced by this pathway 
(Polakis, 2000; Reya and Clevers, 2005).   
 In our studies, various diets containing resistant starches were tested for their modulatory 
effects on the Wnt signaling pathway, using mRNA expression of key genes of this pathway as 
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markers of overall pathway activity.  The first study investigated the effect of diets containing an 
inbred, high-resistance corn line, GUAT, compared to a control inbred line, AR, with highly 
digestible starch, or a naturally hybridized line, ARxGUAT. Diets as fed containing these three 
starches had varying resistant contents with both the AR and ARxGUAT diets having a low level 
of digestion resistance, 5.4±0.5% and 8.6±0.6%, respectively, while the GUAT diet contained 
1.6±0.9% resistant starch.  This study, conducted in male F344 rats fed one of three test diets for 
8 weeks following AOM-injection, investigated effects of a minor increase in resistant content 
(ARxGUAT) compared to control (AR) and a major increase in resistant content (GUAT) 
compared the control (AR) on mRNA expression of genes of the Wnt pathway.  Whole colon 
tissue samples were examined using qRT-PCR analysis for a panel of genes of the Wnt pathway 
or their downstream targets.  Epithelial cell populations of the colonic crypts and lining the 
luminal surface were also microdissected and the expression of two genes, β-catenin, a 
transcription activator, and TFRC, a target gene of the Wnt pathway, was analyzed.  This study 
also measured the incidence and multiplicity of a putative preneoplastic lesion, Aberrant Crypt 
Foci (ACF). 
 Results of this study demonstrated no statistical differences in number of putative 
mucosal lesions, aberrant crypt foci (ACF), among the three diets.  It is worthwhile to note that 
the ability of this lesion to be a reliable marker of colorectal cancer has recently been questioned.  
In this study performed during the pre-neoplastic stage of colon cancer, we identified ACF only 
in AOM-treated rats, suggesting that ACF was induced as a primary or secondary result of AOM 
treatment, but ACFs have not been conclusively shown to represent a preneoplastic condition.  
There was, however, an increase in the average number of crypts per focus in AOM-induced rats 
fed a diet high in resistant starch (GUAT diet), compared with rats fed the readily digestible AR 
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diet.  The absence of a significant difference in crypt multiplicity in colons of rats fed diets 
containing the highly digestible (AR) or moderately digestible (ARxGUAT) starch suggests a 
possible effect of resistant starch on crypt multiplicity (Wargovich, et al., 2010).  Evaluation of 
gene expression using full-thickness samples of colon revealed some statistically significant 
differences in mRNA expression among the various diets, which may prove to be biologically 
significant data.  Rats fed the control diet demonstrate an increased mRNA of Wnt 8a, HNF1α, 
and Axin2 expression in the AOM-initiated mice relative to the saline-injected mice.  However, 
TFRC, SFRP4, and WISP-1 mRNA expression in the full-thickness samples are decreased in 
AOM-initiated mice relative to the saline-injected mice fed the control AR diet.  Diets containing 
moderate or high levels of resistant starch also modify mRNA expression of genes of the Wnt 
signaling pathway. ARxGUAT starch fed to saline-injected mice decreased TFRC, SFRP4, and 
WISP-1 mRNA levels relative to the control AR fed mice injected with saline.  Although these 
three genes play roles in multiple pathways (Rohrs, et al., 2009; Davies, et al., 2010), the ability 
of the ARxGUAT diet to decrease mRNA expression is still important.  ARxGUAT fed in the 
diet not only reduces mRNA expression in saline-injected mice, but also in those injected with 
AOM. β-catenin, HNF1α, SFRP4, and WISP1 mRNA levels are all decreased in the full-
thickness colonic tissue in AOM-injected rats fed the ARxGUAT diet relative to the control, AR, 
fed mice injected with AOM, suggesting that ARxGUAT fed in the diet may be able to down-
regulate the Wnt signaling pathway in an initiated-state.  This study only looked at the 
preneoplastic stage of colon cancer, but the ability of a moderately resistant starch, ARxGUAT, 
in the diet to decrease mRNA expression levels at this stage show the potential for inhibiting cell 
proliferation. 
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 A highly resistant starch, GUAT, in the diet has also demonstrated ability to effectively 
decrease mRNA expression in the full-thickness colon samples and site specific, surface or crypt, 
epithelial cells of the colon.  Mice fed the GUAT diet, injected with saline have decreased TFRC, 
Axin2, SFRP4, and WISP-1 full-thickness mRNA levels relative to the control, AR, fed mice 
injected with saline.  These mRNA expression levels demonstrate that both low and high levels 
of resistant starch content in the diet are able to down-regulate the Wnt signaling pathway.  
GUAT in the diet is able to decrease mRNA expression of Axin2 in the full-thickness colon, 
which was not down-regulated by the ARxGUAT diet.  The decrease of another gene is 
hypothesized to be due to the increased resistant starch content of GUAT and suggests that a 
higher level of resistant starch has a greater impact on maintaining the colon in a normal, non-
initiated, state.  GUAT fed in the diet does not only reduce mRNA expression of the full-
thickness colon in saline-injected mice, but also in those injected with AOM. The Axin2 mRNA 
level of the full-thickness colon is decreased in AOM-injected rats fed the GUAT diet relative to 
the control, AR, fed rats injected with AOM.  The decrease in Axin2 mRNA expression suggests 
an ability of this dietary resistant starch, GUAT, to not only influence expression in a saline-
injected model, but also in an AOM-injected model.  GUAT fed in the diet of rats injected with 
AOM also had a decreased β-catenin mRNA expression both the colonic epithelial surface and 
epithelial crypt relative to AOM-injected rats fed the AR, control, diet.  β-catenin mRNA levels 
are also decreased in the AOM-injected rats fed the GUAT diet relative to the saline-injected rats 
fed the GUAT diet.  Decreased β-catenin levels have been shown to be indicative of a non-active 
Wnt signaling pathway.  This decrease in β-catenin mRNA levels of the full-thickness tissue and 
of the niche specific cells correlates to our mRNA expression data of other key genes in the Wnt 
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signaling pathway, which also point toward a potentially inactive state of the Wnt signaling 
pathway in GUAT-fed rats injected with AOM.   
 Overall, these results demonstrate that increased levels of dietary resistant starch were 
able to modify the expression of genes encoding β-catenin, TFRC, Axin2, SFRP4, and WISP-1 of 
the Wnt signaling pathway in both the full-thickness colon and in the stem cell niche and mature 
surface colonocytes of rats injected with AOM and fed the ARxGUAT or GUAT diet.  The 
GUAT diet was able to decrease the mRNA expression of a few more genes than that of the 
ARxGUAT diet in AOM-injected rats suggesting that the level of resistant content is important 
and that a higher resistant content may be able to decrease overall Wnt signaling to a greater 
degree.   
 With the exception the increased ACF multiplicity, mRNA data suggest an ability of 
GUAT fed in the diet to inhibit the Wnt signaling pathway.  This suggests an ability of resistant 
starch to decrease the mRNA expression of key genes of the Wnt signaling pathway (Giles, et al., 
2003; Segditsas and Tomlinson, 2006).   
 We also demonstrated the important differences in gene expression patterns between 
samples derived from whole tissue and discrete populations of cells residing in different mucosal 
microenvironments.  This highlights the importance of evaluating mRNA levels from specific 
populations of cells.    
 The second study looked at effects of three diets rich in resistant starch of three different 
classifications compared to a control, highly digestible corn starch diet.  Diets containing HA7 
(RS type 2), OS-HA7 (RS type 4), SA-HA7 (RS type 5) or a control corn starch (CS) were fed to 
male A/J mice for 10 weeks following 4 weekly IP injections of either azoxymethane (AOM) or 
physiological saline.  Levels of mRNA expression of several genes of the Wnt pathway or 
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downstream targets were analyzed from populations of cells deep within the colonic crypts to 
evaluate the individual efficacy of the different resistant starches to modulate this pathway.  The 
inclusion of a starch with minimal resistance, OS-HA7, in the diet of mice in the preneoplastic 
stage of colon cancer resulted in a significant increase in the mRNA expression APC, Wnt 5a and 
SFRP4 relative to the mice fed control diet, which may indicate an increase in the Wnt signaling 
pathway activity.   Although β-catenin mRNA expression did not follow this increase, it is 
possible that a secondary mechanism is interacting with and regulating the β-catenin mRNA 
expression (Kwon, et al., 2011).  The inclusion of a highly resistant starch, SA-HA7, in the diet 
at the same stage of carcinogenesis resulted in almost significant decreases in mRNA expression 
of Wnt 5a and a significant increase in mRNA encoding an antagonist, Axin 1, in the AOM-
injected mice relative to the saline-injected mice.  β-catenin mRNA expression of the SA-HA7-
fed mice also did not follow the trend and display a decrease in expression, but instead had an 
increase.  This increase in expression does correspond to both the Wnt 5a and Axin 1 expression 
based on recently reported research, suggesting that excessive translocation of β-catenin to the 
nucleus may induce reduced proliferation of the stem and progenitor cell populations and 
induction of Notch signaling as has been recently suggested (Hirata, et al., 2013).  This 
mechanism is thought to control proliferation by post-translational inactivation of β-catenin and 
would not be detected at the mRNA expression level (Kwon, et al., 2011). 
  Overall, these results demonstrate that the OS-HA7 diet, containing a low level of 
resistant content, was able to both up- and down-regulate the expression of the mRNA for β-
catenin, APC, Wnt 5a, SFRP4, and TFRC of the Wnt signaling pathway in the stem cell niche.  
This suggests that a low level of resistant starch content may not slow cell proliferation and 
differentiation and may instead increase cell proliferation, which may therefore potentiate the 
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development of colorectal cancer.  On the other hand, the results also demonstrate that the SA-
HA7 diet, containing a high amount of resistant starch, has the potential to effectively modify the 
expression of mRNA encoding genes for β-catenin, Wnt 5a, and Axin 1 in the colonic crypt cells.  
With the exception β-catenin mRNA expression, all data suggest an ability of SA-HA7 fed in the 
diet to inhibit the Wnt signaling pathway.  An alternate model of regulation of β-catenin activity 
has been proposed recently in which increased expression of β-catenin mRNA induces post-
translational modifications of β-catenin able to inhibit proliferation of stem and progenitor cells 
through the Notch signaling pathway.  If this model is considered, then the increase β-catenin 
mRNA expression seen in this study may also be indicative of a down-regulated Wnt signaling 
pathway in an AOM-induced state.  This suggests an ability of resistant starch to decrease the 
mRNA expression of key genes of the Wnt signaling pathway. 
 These studies used rodent models of human disease, with model selection being crucial 
for accurate reflection of the disease in human beings.  When studying the effects of diet on 
sporadic colorectal cancer, mouse models with inbred genetic defects are not appropriate for 
investigation of sporadic CRC, as they better mimic inherited forms of human CRC.  Chemically 
induced CRC models, like AOM-treatment of A/J mice, are better suited for these studies, as 
they better correlate to the sporadic colorectal cancer model mimicking a spontaneous DNA 
damage and initiation of carcinogenesis (Hung, et al., 2010).  A/J mice show a dose-dependent 
response to azoxymethane (AOM) and the combination of A/J mice injected with AOM as the 
carcinogen is optimal for this study and further strengthened by the fact that AOM is specific for 
inducing carcinogenesis in the colonic tissue (Bissahoyo, et al., 2005).   
 Both experiments in this project investigated the effects of dietary resistant starch on the 
Wnt signaling pathway, a regulator of colonic carcinogenesis.  To do this, several key genes of 
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the Wnt pathway were chosen for quantative real-time PCR (qRT-PCR).  APC is a tumor 
suppressor gene that acts as a downstream regulator of the Wnt pathway by controlling cellular 
levels of β-catenin (Dimitriadis, et al., 2001).  APC is able to bind both Axin and β-catenin 
which allows for phosphyloration and subsequently degradation of β-catenin.  This prevents 
translocation of β-catenin to the nucleus and initiation of transcription of genes required for 
cellular proliferation (Shibata, 1997).  Defects in regions of either APC or β-catenin that are 
critical to binding will result in a lack of inhibitory binding of β-catenin and subsequent 
uncontrolled transcription.  Transferrin Receptor Protein (TFRC) is a target of the Wnt pathway 
is required for delivery of iron from transferrin to cells, a function that is necessary for cell 
survival.  In an unregulated growth state, such as cancer, TFRC expression would be greatly 
enhanced (Ryschich, et al., 2004).  Most genes of the Wnt pathway that we measured were up-
regulated by AOM treatment and most were down-regulated by diets containing the highly 
resistant starches, GUAT and SA-HA7.  Axin, however, is an antagonist of the Wnt pathway 
whose function is to organize a complex between itself, APC, and β-catenin promoting the 
phosphyloration and degradation of β-catenin.  An up-regulation of this protein results in a 
decreased expression of β-catenin, inhibition of the Wnt pathway and thus decreased cellular 
proliferation rates (Polakis, 2000; Leung, et al., 2002).  This is consistent with both our studies, 
with reduced Axin inhibition of Wnt in rats fed diets containing the highest levels of resistant 
starch, GUAT and SA-HA7. 
 In conclusion, we demonstrate that a high level of resistant starch content in the diet 
modulates the expression of mRNA species integral to the Wnt signaling pathway expression in 
two AOM-induced animal models.  Our studies suggest that enhanced intake of resistant starch 
has the potential to inhibit the Wnt signaling pathway and to provide many health benefits. These 
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studies provide the first research documenting population- and context-specific modulatory 
effects of resistant starches on genes of the Wnt signaling pathway.  The genes in these studies 
may also be prospective targets for the prevention of colorectal cancer, with future studies 
needed to investigate the effects of both AOM and diet on the Wnt signaling pathway at the 
protein and functional levels. 
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APPENDIX A.  EXPERIMENTAL PROTOCOLS 
Title: Starch cooking by water boiling method and diet preparation 
Lab group: Birt/Whitley lab 
Updated by: Bridget Nelson and Nicole Cray 5-31-13 
 
The following SOP outlines the methods for cooking starches and diet preparations. 
 
Starch and Ingredient Storage: 
Starches are stored in closed tubs and stored at 40°F in the HNSB 2007 walk in cooler. Diet ingredients 
and sealed and stored at 40°F in the HNSB LAR diet ingredients coolers. Choline and corn oil are stored 
at room temperature. 
 
Starch Cooking: 
Cooking processes conducted in 2007 HNSB. Starch needed is weighed in a stainless steel pot. Three 
parts water are added for every part of starch weighed out (1 part starch: 3 parts water). The OS-HA7 
starch uses 3 parts water minus 100ml (for dry starch amounts up to 2000g). A wooden spoon is used to 
constantly stir the starch over medium to high heat until starch is cooked to the final endpoints, noted 
below (Figures 1-4). Note that a plastic spoon will melt. Once the final cooked form is observed, the 
starch is placed onto labeled pieces of aluminum foil. Cooking times vary between starch types and 
depend on the amount of starch being cooked. Generally, CS cooks fastest, followed by OS-HA7, SA-HA7, 
and then finally HA7. HA7 burns quickly and needs to be cooked at a lower temperature setting 
(medium low to medium). The cooked starches are then transported to the HNSB LAR diet preparation 
room. 
 
    
Figure 1: Cooked Control starch   Figure 2: Cooked HA7 starch 
 
117 
 
 
 
   
Figure 3: Cooked OS-HA7 starch                                      Figure 4: Cooked SA-HA7 starch 
 
Diet Preparation: 
Diet ingredient amounts are calculated based on the percentages presented in Table 1. If the amount of 
starch made is less than 500g, mixing by hand is preferred over the standard mixer. All dry ingredients 
(not starch) are measured and poured into a plastic mixing bowl. Corn oil is measured last and added 
last. All ingredients are mixed until homogeneous and the final product in dough-like. Trays are covered 
with tin foil and labeled with the diet name, lab name, and date prepared for each diet. The diet dough 
mixture is placed onto the foil covered trays and pressed to various thicknesses: CS-1 inch, HA7-1-1.5”, 
OS-HA7-2-2.5”, SA-HA7-1-1.5”. The diets are left on metal shelves overnight with a fan on a medium 
setting directed at the shelves (Figures 5-8). 
 
Table 1: Diet ingredient components 
Diet Component Percentage of Diet 
Starch 55% 
Casein 20% 
Dextrose 15% 
Mineral Mix 3.5% 
Vitamin Mix 1% 
Choline 0.2% 
Methionine 0.3% 
Corn Oil 5% 
Total 100% 
 
  
Figure 5: CS diet after overnight drying a) top view b) side view, compressed to 1 inch 
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Figure 6: HA7 diet after overnight drying a) top view b) side view, compressed to 1.5 inches 
 
  
Figure 7: OS-HA7 diet after overnight driving a) top view b) side view, compressed to 2 inches 
 
  
Figure 8: SA-HA7 diet after overnight drying a) top view b) side view, compressed to 1.5 inches 
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Title: Diet feeding for animal studies 
Lab group: Birt/Whitley lab 
Updated by: Bridget Nelson and Nicole Cray 6-3-13 
 
The following SOP outlines the methods for feeding animals the resistant starch diets. 
 
1. Weigh and record total weight of each diet before feeding. 
2. Based on the total weight, determine the amount that can be fed to each diet group of animals. The 
average amount of diet per animal per day should be approximately 10-15g, possibly more depending 
on the batch of mice and individuals within the group. 
3. Measure portions of food for each animal based on the amount determined in Step 2 (Figure 1). 
4. Weigh and record leftover diet not used to feed animals. 
5. Refer to Figures 2-4 for adding diet portions to individual cages.  
6. Check back the following day to check the food levels and add more food to animals that are low on 
food. 
 
 
Figure 1:  Measured out food portions for animal feeding. 
 
 
 
Figure 2: Diet placed in cages before compression through metal grates. 
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Figure 3: Compressed diet 
 
 
 
Figure 4: Alternate view of compressed diet 
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Title: Staining slides for LCM 
Lab group: Whitley lab 
Updated by: Nicole Cray 8-2-13 
 
The following SOP outlines the method for staining frozen slides for LCM following the Arcturus 
HistoGene LCM Frozen Section Staining Kit (Life Technologies, Grand Island, NY) Protocol. 
 
Slides stored at -80C until ready 
 
Allow slides to warm up which will take approximately 5 minutes 
 
Then immerse into slide tubes 
75% Ethanol  30seconds 
DH2O   30seconds 
HistoGene Stain 20seconds 
DH2O   30seconds 
75% Ethanol  30seconds 
95% Ethanol  10 dips 
95% Ethanol  30seconds 
100% Ethanol  10 dips 
100% Ethanol  30seconds 
Xylene   2 1/2 minutes 
 
Then transfer the slides to a fresh slide tube of xylene for transport to the LCM machine in 119 
Molecular Biology. 
 
 
 
 
NOTE: This procedure needs to be done in the upmost care to avoid RNA degradation. Only do 
experiments in an area dedicated to RNase free procedures.  Always wear gloves and use RNase Zap 
(Life Technologies, Grand Island, NY) liberally.   
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Title: Collecting Cells Using LCM 
Lab group: Whitley lab 
Updated by: Nicole Cray 8-2-13 
 
The following SOP outlines the method for collecting specific populations of cells using the Arcturus 
PixCell II Laser Capture Microdissection System (LCM) (Life Technologies, Grand Island, NY) in 119 
Molecular Biology. 
 
What is needed: 
Arcturus CapSure HS LCM Caps (Life Technologies, Grand Island, NY)   
Extraction buffer from the Arcturus PicoPure RNA Isolation Kit (Life Technologies, Grand Island, NY)   
RNase spray 
Kim Wipes 
Pipette (10ul) 
Pipette tips 
Desiccator 
Forceps 
Gloves 
Heat Block 
Cap Tray that fits the heat block 
0.5 mL tubes that fit over the cap system 
SAMPLES (carefully transfer in tubes of xylene) 
 
 
Immediately remove slides from xylene and lay out in hood to dry (Room 114) 
-time required depends on weather/humidity levels  
-allow slides to dry completely 
 
While slides are drying, wipe everything with RNase 
-Be thorough 
-As wiping, turn computer, microscope, power box, and tower on 
 
Set Caps into Machine making sure they are secure 
 
Set out all other supplies needed making sure to keep everything RNased 
 
On computer, select the Ver 2.0.0 program 
-Need to select a name and then an experiment 
 
Get slide and place on scope stage 
-focus the slide either through the oculars or on screen 
-move cap onto slide 
-turn on the laser and focus the laser so it is a defined dot 
 
Test the strength of the laser by firing into an empty space on the slide 
-Adjust the power and duration as needed.  (Will need stronger/longer with wet slides.) 
 
Collect as many cells of the population as possible 
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-want enough to fill the cap and do not be afraid to pick up the cap and move it. 
 
When cap is full, lift off the slide and place into cap holder. 
-put cap topper on and fill with 10uL of Extraction Buffer. 
-put 0.5 mL tub on top and ensure whole system is secure. 
 
Cover with heat block until all slides are collected. 
-transport back to 2713 VetMed 
 
Incubate at 42°C for 30 minutes 
-taking care to watch for evaporation due to a loose fit. 
 
Flip apparatus over and spin down at 800g for 1 minute. 
 
Freeze immediately at -80°C OR continue to the RNA collection protocol 
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Title: RNA Isolation 
Lab group: Whitley lab 
Updated by: Nicole Cray 8-2-13 
 
 
The following SOP outlines the methods for RNA isolation following cells collection via LCM. 
 
 
PicoPure RNA Isolation Kit from Arcturus (Life Technologies, Grand Island, NY) using the optional 
RNase-Free DNase Set from Qiagen (QIAGEN, Valencia, CA) 
1. Pipette 250uL conditioning buffer onto purification column filter membrane and incubate at Room 
Temperature for 5 minutes. 
a. centrifuge at 16,000xg for 1 minute 
2. Pipette 10uL 70% Ethanol into cell extract tube from LCM cell collection protocol. 
a. Mix by pipetting up and down and then transfer onto conditioned column (about 20uL). 
3. Centrifuge column at 100xg for 2 minutes then 16,000xg for 30 seconds. 
4. Pipette 100uL Wash Buffer 1 onto membrane and centrifuge at 8,000xg for 1 minute. 
 
 
OPTIONAL DNase Treatment 
I. Pipette 5uL DNase Stock Solution to 35uL Buffer RDD for each sample 
a. Mix by gentle inversion. 
II. Pipette this 40uL mixture onto membrane and incubate at room temperature for 15 minutes. 
III. Pipette 40uL Wash Buffer 1 (above kit) onto membrane and centrifuge at 8,000xg for 15 
seconds. 
 - - - - - - - - - - - - - - - - - - - - - - - - 
 
 
5. Pipette 100uL Wash Buffer 2 onto membrane and centrifuge at 8,000xg for 1 minute. 
6. Pipette another 100uL of Wash Buffer 2 onto membrane and centrifuge at 16,000xg for 3 minutes. 
7. Transfer the column to a new 0.5mL tube (in kit). 
8. Pipette 30uL Elution Buffer directly onto membrane (touch tip to membrane with care). 
a. Incubate at room temperature for 1 minute. 
9. Carefully centrifuge at 1,000xg for 1 minute and then 16,000xg for 1 minute. 
10. Remove membrane and close tube. 
a. Nanodrop then freeze. 
 
 
 
Check RNA content using nanodrop (2758 VetMed) ~25ng/ul (Note that this is low) 
RNA samples store in -80°C freezer after the isolation 
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Title: cDNA synthesis 
Lab group: Whitley lab 
Updated by: Nicole Cray 8-2-13 
 
The following SOP outlines the methods for cDNA synthesis following RNA extraction. 
Up to 24 extracted/purified RNA samples can be converted to DNA in one run.  Thaw RNA samples 3-5 
minutes. 
 
iSCRIPT cDNA synthesis kit from Bio-rad (BioRad, Hercules, CA)  
Add together: 
4 ul 5x iScript Reaction Mix 
1 ul iScript Reverse Transcriptase 
15 minus X ul Nuclease free water 
X ul RNA template (for x amount of template: up to 1ug) 
Total=20 ul 
Mix together in 0.2 ml thin wall tube and put in PCR thermal cycler machine 
Run at: 
5 min at 25 C 
30 min at 42 C 
5 min at 85 C 
Hold at 4 C 
  
Use VetMed GeneAmp PCR System 2400 located in room 2605 
Protocol = USER: Nicole METHOD: cDNA 
Check DNA content using nanodrop (2758 VetMed) ~1200-1500ng/ul 
cDNA samples store in -80°C freezer after the synthesis 
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Title: qRT-PCR 
Lab group: Birt/Whitley lab 
Updated by: Nicole Cray 8-2-13 
 
The following SOP outlines the method for qRT-PCR following cDNA synthesis using the GeneAmp 5700 
Sequence Detection System in VetMed 2605. 
 
Bio-Rad iQ SYBR Green Supermix (BioRad, Hercules, CA).   
 
12.5 ul SYBR Green Supermix 
10 ul Nuclease free water 
0.5 ul F primer (10pmol/ul) 
0.5 ul R primer (10pmol/ul) 
1.5 ul cDNA sample (1200-1500ng/ml) NC does not dilute cDNA due to low reads 
 
Blank samples include every ingredient except for the cDNA sample. The 1 ul difference is made up by 
adding 1ul additional nuclease-free water. 
 
qRT-PCR protocol: 
95C 3 min 
 
95C 15s 
62C 30s Repeat for 40 cycles   (Note: 62 and not 60 here) 
72C 30s 
 
95C  1 min 
55C 1 min 
Hold at 55C 
 
 
How to dilute primer: 
1. Spin down primers to get them all at the bottom of the tube. 
2. Check specifications on primer tubes—usually 100nmol 
 Ex. If the tube says “a nmol=b g”, then add 10*a ul TE buffer to dilute to 100pmol 
  85.5nmol=0.83ng, then add 855 ul TE buffer to get to 100pmol 
3. Further dilute to 10pmol for qRT-PCR with RNase-free water (20ul sample to 180ul RNase-free water) 
 
 
 
 
 
 
 
 
 
 
